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Pelvic floor disorders account for the weakened function of muscles and surrounding 
tissues with one of the most prevalent conditions being pelvic organ prolapse (POP). Over a million 
women each year in the United States are affected with over a quarter undergoing a reconstructive 
procedure, increasingly using polypropylene mesh. While mesh may provide the mechanical 
support necessary to treat POP, serious complications such as exposure, erosion, contraction, and 
pain limit successful outcomes in the long term. Researchers have found an increased 
inflammatory response to mesh to be correlated with mesh complications, both pre-clinically and 
in the clinic.  The host-biomaterial interaction, with a specific focus on early macrophage behavior, 
has been accepted as an indicator of implant integration in the long term. However, to date, most 
research on the host response to mesh has not been performed using a relevant animal model, or 
has only been evaluated in the long term.   
The present dissertation focuses on understanding the tissue specific micro-environment of 
pelvic floor repair by employing the New Zealand white rabbit to perform a “gold standard” 
lumbar colpopexy procedure to evaluate changes in the immunologic response at acute (14 days) 
stages and tissue remodeling outcomes at late stages (90 days) of mesh implantation. Additional 
comparisons were made with subcutaneous implantation sites relevant from previous models 
studying host response. Histological and gene expression analysis found evidence of acute and 
chronic inflammation surrounding mesh implants with tissue degradation and unresolved 
 v 
inflammation. An overall heightened host response in vaginally implanted meshes was observed 
when considering macrophage presence, collagen deposition, elastic fiber changes and vascularity.  
Further work to mitigate the observed tissue degradation and inflammation involved the 
immunomodulatory strategy of delivering interleukin-4 (IL-4) during the early stages of the host 
response. Studies in a mice subcutaneous implantation model have shown success in reducing 
fibrous capsule formation and encouraging a pro-remodeling response. We have taken this a step 
further in a novel clinically relevant New Zealand white rabbit lumbar colpopexy model. Results 
showed overall increased anti-inflammatory cytokine expression, with decreased tissue 
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1.1 Pelvic Organ Prolapse (POP) 
Pelvic organ prolapse is a condition characterized by the weakening of pelvic floor muscles 
over time resulting in the downward shift, or herniation of the pelvic organs into or beyond the 
vaginal canal. The vagina along with its connective tissues and muscles provides direct support to 
the pelvic organs, including the urethra, bladder, uterus, and rectum [2-6]. However, factors such 
as menopause, obesity, age, vaginal birth, congenital or acquired connective tissue abnormalities 
increase the susceptibility to experiencing pelvic organ prolapse [4, 7, 8].  While POP is not life 
threatening, symptoms such as pelvic pressure, observing a bulge protruding past the vaginal 
opening, pain with daily activities as well as dyspareunia, along with disruptions in bowel and 
urinary behavior can have a lasting impact on the quality of life for women [9-11]. While the 
degree and type of prolapse can vary, about 41% to 50% of the female population have presented 
symptoms of prolapse upon physical examination [12]. It is estimated that the number of women 
who have POP in the United States will increase by 46% to an approximate 4.9 million women by 
the year 2050 [12].  
There are many variations in the types of prolapse that women may experience (See Table 
1). Upper vaginal prolapse or vaginal vault, can occur after hysterectomy, when the top of the 
vagina descends down and bulges outward. Uterine prolapse is when the uterus descends into the 
vagina. Cystocele, or anterior vaginal wall prolapse, is when the bladder shifts downward, creating 
the bulge. Urethrocele is another form of the anterior vaginal wall prolapse, where the urethra will 
 2 
fall into the anterior vaginal wall. Enterocele is when small bowel sinks into the posterior vaginal 




Table 1: Classifications of Pelvic Organ Prolapse 
Prolapse Type Prolapse Description 
Cystocele Prolapse of the bladder into upper anterior vaginal wall 
Urethrocele Prolapse of the urethra into lower anterior vaginal wall 
Enterocele Prolapse of the small bowel into the upper posterior vaginal 
wall 
Rectocele 
Prolapse of the rectum into the posterior vaginal wall 
Uterine prolapse 
Prolapse of the uterus into the vagina 
Vaginal Vault  Prolapse of the top of the vagina descends down, also known 




POP patients often experience other forms of pelvic floor disorders in conjunction with 
their prolapse symptoms. It has been found that approximately 40% of POP patients have stress 
urinary incontinence, 50% experience fecal incontinence, and 37% have symptoms of an 
overactive bladder [11].   
 3 
 Anatomy of the Pelvic Floor 
In the female pelvis, the anatomical support of the pelvic organs is provided by a 
physiologically intricate relationship between the pelvic floor muscles and connective tissue 
attachments. The pelvic floor muscles, also known as the levator ani muscles, hold the pelvic floor 
closed in such a way that usually prevents the abnormal descent of the pelvic organs. They consist 
of the coccygeous, pubococcygeous, ileo coccygeous muscles and it is through isotonic contraction 
that provides mechanical support to the pelvic organs [3-5, 14-24]. The connective tissue structural 
support is characterized by three levels, each with distinct contributions. Level I is defined by the 
cardinal and uterosacral ligaments attaching the upper third of the vagina and the cervix to the 
pelvic walls. Level II support is defined by the paravaginal attachment of the middle of the vagina 
laterally to the pelvic sidewalls via the arcus tendinous fascia. Level III is characterized by the 
distal vagina attachment to surrounding structures such as the levator ani muscles and the perineal 
body via endopelvic fascia [2-4, 25].   
It is specifically loss of apical support (Level I) or a combination of these levels that has 
been found to contribute towards the development of POP [4, 5].  
 Clinical Treatment Options 
Current statistics from the U.S. Food and Drug Administration (FDA) state that 
approximately 12.6% of women will undergo surgery to repair pelvic organ prolapse (POP) during 
their lifetime [12, 26, 27]. While treatment is individualized to each patient’s circumstance and the 
symptoms that are being experienced, the primary goal is to always improve the condition and 
minimize any further progression. At times, this can be achieved with conservative nonsurgical 
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options, such as the use of a vaginal pessary, or with increased pelvic floor muscle training 
exercises. However, there are circumstances that necessitate a reconstructive surgery to correct 
POP by restoring mechanical support to the pelvic floor. This is done once a physician has 
completed the pelvic organ prolapse quantification system exam otherwise known as POP-Q [13]. 
It provides a standardized method of classifying the array of symptoms experienced by women 
through a series of defined anatomical points that serve as landmark references. During 
examination, physicians can determine any prolapse development through changes in 
measurements from these references. For example, the degree of prolapse is described in stages 





Figure 1 POP-Q landmark references and points referring to the range of values for quantitative 





When it comes to surgical treatment, there are a wide variety of both abdominal and vaginal 
approaches that can be considered to resuspend the vaginal apex and anterior and posterior vaginal 
walls (See Table 2). It is well recognized that providing robust apical support is a fundamental 
component of successful long-term POP repair [28].  
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Table 2: Surgical Approaches to treat Pelvic Organ Prolapse 
Vaginal Approaches [6, 29] 
Colporrhaphy Anterior or posterior vaginal wall repair 
McCall culdoplasty 
Attaching uterosacral and cardinal ligaments 
to the peritoneal surface 
Manchester repair 
Amputation of the cervix with uterus 
suspension to the cardinal ligaments 
Prespinous & sacrospinous colpopexy 
Attachment of uterus or vagina to sacral 
anterior ligament 
Abdominal Approaches (Either through open incision or via laparoscope)[6, 29]  
Sacral colpopexy 
 
Attachment of uterus or vagina to sacral 
anterior ligament 
Paravaginal repair 
Attaching pelvic organs (bladder and urethra) 
to pelvic sidewalls 
Vault suspending and uterosacral ligament 
plication 
Suspending uterosacral ligament to the sacrum 
Enterocele ligation and posterior vaginal wall 
repair 
Repair surgery to stop rectum from bulging 




A variety of research has found that the sacral colpopexy surgical method has been 
associated with the best outcomes in terms of durability when compared to other procedures, 
especially those of the transvaginal route [30, 31]. However, the risk of recurrence still exists and 
it has been estimated that between 10 - 30% of all procedures required a secondary and sometimes 
multiple operations to resolve complications or recurring symptoms [9].  
There are four classes of reconstructive materials used in the procedure to provide restore 
mechanical support that include: biologic, non-absorbable synthetic, absorbable synthetic, and 
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composite (any combination of the previous three). Autologous repairs are utilizing the patient’s 
own native tissues for repair, however there is a higher chance of recurrence (40%) [9, 32]. 
Biologically derived materials such as allografts and xenografts create extracellular matrix 
scaffolds, but also have been shown to lack the mechanical robustness needed to provide 
reconstructive support long-term. Synthetic mesh materials such as polypropylene are increasingly 
used in reconstructive procedures, and maintain the mechanical strength necessary to provide 
support. However, the use of mesh is also not without complications, such as chronic pain, mesh 
erosion and exposure through the neighboring tissues [33-35].  
 Complications  
The use of polypropylene mesh in pelvic floor repair has led to a significant reduction in 
the recurrence of prolapse, but is also associated with complications, including chronic pain and 
mesh erosion/exposure [9, 12, 36, 37]. In a meta-analysis conducted by the FDA reported in early 
2019, 11 – 18% of women implanted with mesh experienced these complications in a time period 
of 1 – 6 years after prolapse repair, thus requiring surgical correction [12]. 
Further assessment has found that mesh-related complications are dependent on the 
anatomical placement of mesh during POP repair. It has been shown that abdominal approaches 
were associated with approximately 30% lower rate of complications than a transvaginal approach 
after 7 years post-surgery [38]. Additionally, complications can be correlated with two distinct 
pathways of failure. Mechanical mismatch and an unresolved inflammatory response leading to 
poor tissue integration are widely accepted phenomena associated with the failure of mesh in pelvic 
floor repair [9, 37, 38].  
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Synthetic mesh has originally been used to repair abdominal hernias for over half a century. 
Medical device companies, through 510k and the 1976 Medical Device Amendments Act, were 
able to resell the hernia repair mesh as a treatment for pelvic organ prolapse [26, 27]. However, 
with the increasing complications, in 2008 and 2011, the US Food and Drug Administration issued 
warnings to doctors and patients about mesh [27]. In January of 2016, the US Food and Drug 
Administration officially reclassified surgical mesh for transvaginal repair of pelvic organ prolapse 
from a class II, moderate risk device, to a class III, high-risk device [26].However, most recently 
in 2019, the sale of mesh intended for transvaginal repair was officially banned [12]. It is clear that 
there are deeper considerations that impact the understanding of the host response to synthetic 
mesh in vaginal tissue. Hernia repair focuses predominantly on the anatomical location of the 
abdomen and the transition to vaginal repair introduces increased vulnerabilities via inflammation 
and changes in the mechanical stresses.   
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2.0 Foreign Body Response to Mesh 
While the material and mechanical properties associated with biomaterial implants are of 
significant importance both at the time of implantation and for the long-term function of materials 
within the body, the host inflammatory response which occurs at the host-biomaterial interface has 
long been considered as a key predictor of downstream success. That is, even in the presence of a 
robust design which meets the mechanical requirements at the site of implantation, materials may 
fail due to a reaction which degrades or inhibits their proper function over time.  Such reactions 
have been a topic of study for many decades and advances in the understanding of the host response 
has been used to drive the development of novel materials and modification strategies.   
It is well known that as soon as a material is implanted in the body, an orchestrated 
progression of cellular and biochemical phenomena including blood-material interactions, 
provisional matrix formation, acute inflammation, chronic inflammation, granulation tissue 
development, foreign body reaction, and fibrotic tissue deposition [1, 39-41].  The mechanisms 
underlying each of these phenomena have been studied in-depth and multiple strategies for their 
modification have been proposed in the field.   
2.1 Acute vs. Chronic Response 
The inflammatory response can be divided into two broad categories based upon temporal 
activities that have been widely observed, the acute phase and chronic phase of inflammation. The 
acute inflammatory stage begins immediately after implantation and can last two to four weeks. 
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Host proteins adsorb onto the implant surface and within hours the presence of neutrophils is 
observed, reacting by producing cytokines, chemokines, reactive oxygen species, and other 
enzymes such as metalloproteinases that lead to the recruitment of macrophages over the next few 
days [1, 39, 40, 42].  The presence of macrophages also leads to further secretion of cytokines, 
which, depending on the degradability and surface properties of the implant, will continue the 
inflammatory process [1, 39, 40]. Simultaneously, angiogenic factors are released and 
lymphocytes continue the inflammatory process. However, when the acute inflammatory response 
does not eliminate the invading foreign agent, the response moves into the next stage of chronic 
inflammation. At this point, macrophages can fuse into a foreign body giant cells, fibroblast 
recruitment is promoted, and an increased extracellular matrix can be observed surrounding the 
implant [1, 39, 40]. It is at this stage, where subsequent development of a dense collagen capsule 
with decreased potential for vascularization, that the implant may result in failure for its intended 
purpose.  
2.2 The Role of Cytokines 
Table 3 lists the critical cytokines present during the foreign body response which provide 
functional events determining later stages of inflammation. These will be referenced later in 
discussion. Cytokines are considered the molecular messengers that provide the necessary signals 
for inflammatory or anti-inflammatory events, such as macrophage activation that will determine 
immune response outcomes including collagen formation and angiogenesis [40, 43].  
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Table 3: Cytokines involved in wound healing and the foreign body reaction. Retrieved from [1] 
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2.3 The Role of Macrophages 
Macrophages are widely accepted as protagonists during the inflammatory process. 
Preliminary work has shown that the implantation of mesh is associated with a foreign body 
response, consisting predominantly of activated, proinflammatory M1 macrophages [33, 44, 45]. 
It is commonly known that macrophages can exist on a spectrum ranging from the classically 
activated, M1 type to the alternatively activated, pro-remodeling M2 phenotypic profile depending 
on the nature of signaling cues received [44, 46-49]. Previous evaluation of the host response to 
mesh implanted in human patients who experienced complications found a prolonged presence of 
the activated, pro-inflammatory response lasting beyond 8 years (30, 31).  
Classically activated macrophages appear initially to the site of injury and proceed with 
phagocytic functions and the production of oxidative metabolites and pro-inflammatory cytokines. 
Typically, there is a phenotypic switch to the anti-inflammatory M2 macrophage population, with 
an upregulation of anti-inflammatory cytokines focused on tissue remodeling and constructive 
processes to resolve inflammation.  
Macrophage polarization is a concept that is a focus for immunomodulation. It is widely 
known that shifting the macrophage phenotype during the foreign body response from the pro-
inflammatory profile to the more anti-inflammatory, pro-tissue remodeling profile early on after 
implantation of a biomaterial has been associated with a beneficial host response [44, 49, 50]. It 
has also been correlated with better integration of the implant into the surrounding tissue, thus 
mitigating the negative effects of a chronic inflammatory response.  
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3.0 The Concept of Immunomodulation 
There have been many developments in strategies to modulate the immune response to 
biomaterials specifically related to macrophage polarization. Macrophage polarization has been 
modeled in vitro with the administration of cytokines capable of shifting phenotypic properties. 
Inflammatory mediators (lipopolysaccharide (LPS) and interferon-gamma (IFN-γ) are known to 
activate the M1 macrophage phenotype. Interleukin-4 (IL-4), interleukin-13, (IL-13) and other 
cytokines are known to support activation of the M2 macrophage phenotype. Immunomodulatory 
approaches focus on the temporal release of specific cytokines or other molecules capable of 
mitigating inflammation and promoting a regenerative bioactive response.  
While there are strategies that have focused on inhibiting the effects of known pro-
inflammatory agents, such as tumor necrosis factor alpha (TNF-α) and have shown promise for 
faster wound healing, there is increased attention towards strategies of promoting the phenotypic 
shift of M1 towards an M2-like profile during the early stages of the immune response [44, 45, 49-
51]. This is accomplished using anti-inflammatory agents, such as interleukin-10 (IL-10), IL-4, 
IL-13, or even glucocorticosteroids. However, the method of exposing macrophages to these 
crucial mediators is also an area of development in which researchers will embed the molecules in 
a material scaffold and utilize different controlled release strategies [45, 50, 52-57]. Scaffolds can 
range from materials such as synthetic polymers to extracellular matrix derived biologic scaffolds. 
These strategies are motivated by the natural healing process of tissues. To date, preclinical 
findings have shown potential, more research is needed to move forward with clinical studies of 
such approaches.  
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3.1 Layer-by-Layer 
The last decades have brought significant development in the field of novel materials as 
well as the available methods of modifying the surface of implants. This has led to an array of 
changing properties increasing the characteristics associated with the host material. While there 
are numerous methods to fabricate a polymer film, the layer-by-layer assembly method provides 
many benefits in its mild process including versatility and the ability to incorporate functional 
biomolecules. Using the concept of electrostatic interactions, the layer-by-layer method quite 
literally refers to the deposition of alternating layers of a cationic polyelectrolyte followed by an 
anionic polyelectrolyte. This mechanism can be applied to several charged materials, including 
nucleic acids, saccharides and other proteins.  However, in our laboratory, a previously developed 
layer-by-layer system incorporating chitosan as a cationic polymer and dermatan sulfate as an 
anionic polymer has shown great success in the release of bioactive IL-4 [50]. While the 
applications of layer-by-layer technology can go beyond what will be discussed further in this 
dissertation, there are several aspects of using polyelectrolyte layers for the release of bioactive 
molecules that highlight implant functionality.   
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4.0 Animal Models Examining Mesh Host Response 
There are many in vivo models utilized to undergo the vast task of understanding the host 
response to mesh. Animal surgical models continue to be an essential component in preclinical 
testing. However, there are several models that can accurately represent the pathophysiological 
parameters surround pelvic organ prolapse.  
Rodents have been previously employed to assess the inflammatory response to materials, 
especially at the early stages of development. Subcutaneous and partial thickness abdominal wall 
defects are common procedures providing detailed information on material-tissue interactions.  
More recently, a lysyl oxidase like-1 (LOXL1)-deficient group of mice have been used as a 
clinically relevant parallel to prolapse, having found that LOXL1-deficient mice develop prolapse 
after delivery [58, 59]. This comes with the knowledge that LOXL1 is the enzyme critical in elastin 
metabolism and thus removing it from mice allows researchers to mimic prolapse symptoms due 
to the associated weakness in the pelvic floor [59]. Other groups have looked at fibulin-5 knockouts 
in mice or disrupting motifs that are responsible for the matrix metalloproteinases [59-61]. 
Previous work using modifications such extracellular matrix coatings or incorporation of 
immunomodulatory cytokines has also served as the groundwork towards shifting to a larger 
animal model, thereby enhancing preclinical knowledge [50, 62].   
To date, rabbit studies have focused on the external vagina in which the mesh is simply 
placed under the vaginal wall and therefore, do not mimic a prolapse surgical repair [42, 63]. 
Additionally, there are several studies that have also continued the trend of abdominal wall 
implantations in rabbits, which cannot necessarily relate back to prolapse repair [64, 65].  
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Sheep closely mimic the anatomical and physiological properties of the female pelvic floor, 
and was shown to elicit the same mesh placed in the abdominal wall and implanted transvaginally 
found greater fibrotic response and tissue degradation in the vaginal implants. However, the use 
of a sheep model has resulted in numerous studies of implanting mesh in the abdominal wall and 
transvaginally [64, 66-69].   
A nonhuman primate sacrocolpopexy model allows for the gold standard pelvic floor repair 
procedure. Numerous studies have contributed significantly to the field in discovering the effects 
of mesh implantation on vaginal tissues. Researchers found substantial reduction in the vaginal 
smooth muscle layer along with decreased collagen and elastin content and increased active 
metalloproteinases, all indicative of vaginal degeneration [35, 70, 71]. While nonhuman primate 
model outcomes have provided tremendous insight into the mechanisms behind complications, the 
host response has only been observed at later time points (> 3 months) due to the high cost and 
limited availability of this model.  
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5.0 Hypothesis and Specific Aims 
In order to better understand vaginal tissue degradation in mesh implantation patients, the 
current dissertation describes the development and utilization of a surgical model to assess the 
impact of different microenvironments based upon anatomical location. As noted previously, the 
early host response in a clinically relevant environment remains largely uncharacterized. Based on 
previous contributions from animal models of mesh implantation, our research objective consisted 
of two main aims.  
Aim 1: To develop and utilize a clinically relevant rabbit pelvic prolapse 
reconstruction model to assess the host response to implanted mesh in the vagina and 
abdomen.  
Sub Aim 1.1: To analyze the tissue composition in the abdomen and vagina, and how that 
deviates with the implantation of polypropylene mesh at early inflammatory and late tissue 
remodeling time points. 
Hypothesis: Implantation of mesh in the vagina and abdomen will be consequently 
associated with an increased inflammatory profile in the vagina related to increased tissue 
degradation downstream. We hypothesize differences in the extracellular matrix deposition based 
on the anatomical location at early and late time points, such that the abdomen is not a 
representative indicator of mesh implantation outcome in the vagina.  
Aim 2: To scale up the controlled release of IL-4 from a layer-by-layer coating as an 
immunomodulatory strategy to improve downstream outcomes following mesh 
implantation. 
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Hypothesis: The controlled release of IL-4 from a coated mesh will modulate the immune 
response to promote an improved tissue remodeling and decreased inflammatory response.  Thus, 
modifying the polypropylene mesh to maintain its original functionality but with a coating using 
a drug delivery mechanism to release cytokines to promote tissue remodeling will be beneficial in 
creating an enhanced mesh implant associated with improved tissue integration post-implantation.  
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6.0 Aim 1: To Utilize a Clinically Relevant Rabbit Pelvic Reconstruction Model to Assess 
the Acute and Chronic Host Response to Polypropylene Mesh in the Vagina and the 
Abdomen 
6.1 Introduction 
Previous studies of clinically available as well as novel biomaterials have shown that the 
early inflammatory profile following implantation is a strong indicator of overall tissue integration 
downstream across multiple tissue and organ systems [33, 42, 44, 50, 72-74]. However, the early 
host response to polypropylene mesh in the vaginal microenvironment remains largely unstudied. 
While a nonhuman primate sacrocolpopexy model allows for the gold standard pelvic floor repair 
procedure, the host response has only been observed at later time points (> 3 months) due to the 
high cost and limited availability of this model [33, 64, 71]. Similarly, a sheep model has resulted 
in numerous studies of implanting mesh transvaginally, but the same constraint of a later time 
point (> 3 months) remains [64, 66, 67, 69]. While there is prior work conducted in a rodent 
abdominal defect model defining the response at earlier time points, the host response to mesh in 
this model is not truly representative to a relevant pelvic floor model [62, 64, 68, 74-77]. To date, 
rabbit studies have focused on the external vagina in which the mesh is simply placed under the 
vaginal wall and therefore, do not mimic a prolapse surgical repair [63, 73]. Thus, there is a clinical 
need for a cost-effective model that allows for the assessment of biomaterials in relevant 
anatomical locations at time points relevant to shifts in the immune response.  
A rabbit lumbar colpopexy model may represent an ideal, cost-effective model system due 
to the ability to create an adapted method of pelvic reconstruction closely mimicking 
sacrocolpopexy affording the possibility of assessing early and late immune responses. In this aim, 
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Gynemesh PS (Ethicon, Somerville, NJ), a commercially available polypropylene mesh, was 
implanted via lumbar colpopexy in 6-month-old New Zealand white rabbits. At 14- and 90-days 
post-implantation, the mesh-vagina complexes were extracted for evaluation of the acute and 
chronic immune and tissue remodeling response. Results from this aim provided insight into the 
dynamic remodeling process of the mesh host response captured in a clinically relevant model.   
6.2 Materials & Methods 
 Animal Subjects 
A total of 12 nulliparous New Zealand White Rabbits aged 4 – 6 months (~4 kg) were used 
in this study. Animals were obtained from Covance, Inc. (Princeton, NJ). All animals were housed 
in the Center for Preclinical Studies at the McGowan Institute for Regenerative Medicine (MIRM) 
for at least 7 days prior to the start of any procedure. All animals were examined by staff 
veterinarians and determined to be in good health prior to admission into any study. All animals 
were monitored daily. All procedures were approved by the Institutional Animal Care and Use 
Committee at the University of Pittsburgh.  
Rabbits were kept with fresh bedding and enrichment along with access to food and water 
in accordance to National Institutes of Health Animal Care Guidelines for rabbit care. Extra 
enrichment was provided in the form of preferential snacks such as blueberries, pineapple, celery, 
strawberries, grapes and romaine lettuce. The rabbits were exposed to a 12-hour light/dark cycle 
and monitored for signs of distress throughout the study.  
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 Surgical Design (Lumbar Colpopexy vs Subcutaneous) 
Rabbits were sedated with acepromazine (1 mg/kg) followed by intramuscular injection of 
ketamine/xylazine (35 mg/kg & 5 mg/kg).  Animals were then incubated and a surgical plane of 
anesthesia was achieved via inhalation of 2% isofluorane.  
A midline longitudinal incision was performed opening the peritoneal space with the 
bowels packed away followed by identification of the uterine horn and reproductive organs (Figure 
2A). A hysterectomy was performed followed by trimming and collection of the proximal vagina 
of the rabbit to serve as a positive control for histological, biochemical and gene expression 
analysis (Figure 2B). Once the uterus was removed, space was dissected along the vaginal wall on 
both sides between the bladder and the rectum (Figure 3A). Two 3 x 12 cm2 pieces of Gynemesh 
PS (Ethicon, Somerville, NJ) were secured with 3-0 PDS suture along the posterior and anterior 
vaginal walls (Figure 3B). The remaining flaps at the top were then attached to a ligament in the 
lumbar spine with 2-0 PDS creating support to the pelvic organs (Figure 4A & 4B). The peritoneal 
cavity was continuously hydrated (Figure 5) and sutured closed with continuous stitching using 3-
0 PDS. A 2 x 2 cm2 piece of mesh was implanted subcutaneously (Figure 6B) onto the abdominal 
musculature via 3-0 PDS prior to closing the initial abdominal incision in the skin with subcuticular 
stitches. Post-surgically, all animals were monitored closely to ensure full recovery from 
anesthesia.   
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Figure 2: A. Identification of the uterus prior to performing hysterectomy B. Partial removal of proximal 
vagina. All scale bars indicate 0.5 cm. 
 
 
Figure 3: A. Dissection away from rectum and posterior vagina. B.  Attachment of mesh along vaginal wall. 





Figure 4: A. Suturing through ligament in lumbar space for proximal attachment B. Attaching suture 
through ligament for anchoring at lumbar (Blue arrows indicate suture needle through ligament). All scale 
bars indicate 0.5 cm. 
 
 






Figure 6: A. Mesh attached to vaginal wall and secured to ligaments completing lumbar colpopexy procedure 
B. Mesh implanted in the subcutaneous space. All scale bars indicate 0.5 cm. 
 
 
 Post-operative Care 
Animals were carefully monitored for signs of discomfort (as evidenced by failure to eat, 
drink, or resume normal ambulation and activity). Cefazolin (25 mg/kg), Buprenex (0.02 mg/kg), 
and Ketoprofen (2 mg/kg twice daily as needed) was given via subcutaneous injection for pain for 
3 days postoperative. At the veterinarian’s discretion, the animals were given Ranitidine (2 mg/kg) 
as an antacid in cases of a decreased appetite until normal activity resumed. 
 Tissue Explants and Tissue Processing 
At 14 days and 90 days post-implantation, the animals were sedated with acepromazine (1 




mesh and surrounding tissue were extracted from the rabbit and immediately processed. One 
portion of a representative mesh-tissue explant (Figure 7A & 7B) was fixed in formalin for at least 
48 hours before paraffin embedding. 7 m sections were used for histological analysis. Another 
portion of the explant was flash frozen and kept in -80°C for biochemical evaluations. A 3x3 cm2 






Figure 7: A. Representative image of excised vaginal tissue B. Representative image of excised subcutaneous 




Figure 8: Histological Representation of Explanted Tissue A. Control vaginal tissue extracted during 
hysterectomy procedure. B. Representative vaginal-mesh tissue cross-section depicting tissue layers C. 
Representative subcutaneous-mesh tissue cross-section 
 
 
 Histology (H&E) Tissue Morphology and Characteristics 
Tissue sections were stained with hematoxylin and eosin to observe key aspects of the host 
response to mesh including tissue organization, degradation and encapsulation. Specifically, tissue 
sections were analyzed with an emphasis regarding mononuclear cellular infiltration near mesh 
fibers, the presence of foreign body giant cells and potential angiogenesis.  Cellularity analysis 









was based on 5 to 7 single mesh fibers imaged per sample at a 40X objective on Nikon Eclipse 50i 
(Nikon, Tokyo, Japan) and using Fiji image processing software (National Institutes of Health, 
Bethesda, MD).  
 
 
Figure 9: Representative image of mesh fiber at 40X objective (shown by *) and utilization of Fiji software for 
cellularity counts shown in blue 
 
 Collagen Staining & Quantitative Analysis 
6.2.6.1 Masson’s Trichrome 
Tissue sections stained with Masson’s trichrome were imaged to observe the collagen 
deposition within the implantation site. Briefly, sections were immersed in Bouin’s solution at 
56C for 15 minutes, with subsequent washing steps. Sections were then stained with Weigert’s 
Iron Hematoxylin Working Solution for 5 minutes and lastly immersed in Trichrome AB solution 
* * 
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(Sigma, St. Louis, MO) for 5 minutes. All analysis of collagen area surrounding mesh fibers was 
based on 5 to 7 single mesh fibers per sample imaged at 20X objective on Nikon Eclipse 50i 
(Nikon, Tokyo, Japan). Fiji image processing software (National Institutes of Health, Bethesda, 
MD) provided a quantitative assessment of the fibrous capsule thickness surrounding the mesh 
fibers. 
 
Figure 10: Example of color deconvolution algorithm for quantification of fibrous collagen capsule thickness 
distinguishable in blue channel. Images shown are 20X magnification. 
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6.2.6.2 Picrosirius Red 
Sections were immersed in Weigert’s Hematoxylin for 8 minutes, followed by washing 
steps and incubation in Picrosirius Red for 1 hour. Picrosirius red staining of the mesh and 
surrounding tissue can demonstrate the size and maturity of the surrounding collagen fibers inside 
the fibrous capsule surrounding the implanted mesh. A custom algorithm in Matlab (MathWorks, 
Natick, MA) was used to quantify the fibers based on thickness and type of collagen, through 
polarized light in red (thickest fibers), orange, yellow and green (thinnest fibers). Analysis was 
also based on imaging 5 to 7 single mesh fibers per sample taken at 20X field on TE-2000-E 
inverted Nikon through polarized light (Nikon, Tokyo, Japan).  
 Macrophage Immunohistochemistry (Peroxidase)  
Sections were deparaffinized and rehydrated in a graded series of alcohols followed by 
antigen retrieval in citric acid buffer (pH 6.0) for 20 minutes at 95C. Sections were then incubated 
in 3% hydrogen peroxide in methanol for 30 minutes at RT to block endogenous peroxidases. 
Tissue sections were blocked in a blocking solution of 5% Donkey Serum, 2 % Bovine Serum 
Albumin, 0.1% Tween-20, 0.1% Triton-X-100 for 2 hours at RT in a humidity chamber. Slides 
were immunolabeled using either monoclonal mouse anti-rabbit RAM11 (1:200) (Dako North 
America, Inc., Carpinteria, CA), a pan-macrophage marker, overnight at 4C. After PBS washes, 
sections were incubated in a secondary biotinylated anti-mouse IgG (1:200) (Vector, Burlingame, 
CA) for 30 minutes at RT followed by incubation in Vectastain Elite Avidin/Biotin Complex 
(ABC) Reagent (Vector, Burlingame, CA) for 30 minutes at RT. Tissue section were then 
incubated with DAB (3,3’-diaminobenzidine) HRP substrate until dark brown reaction was visible. 
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Vector Hematoxylin QS was used to counterstain the nuclei followed by a dehydrated series of 
alcohols and mounting coverslips for imaging. Images of 5 to 7 single mesh fibers per sample were 
taken at 40X objective for RAM11+ on Nikon Eclipse 50i (Nikon, Tokyo, Japan) and using Fiji 
image processing software (National Institutes of Health, Bethesda, MD). 
 
Figure 11: Representative image of mesh fiber shown at 40X objective (shown with *) and RAM11 
immunolabeling followed by the utilization of image processing software for RAM11+ counts shown in blue. 
 
 
 CD31 Immunohistochemistry & Vessel Analysis 
Sections were deparaffinized and rehydrated in a graded series of alcohols followed by 
antigen retrieval in citric acid buffer (pH 6.0) for 20 minutes at 95C. Sections were then incubated 




Tissue sections were blocked in a blocking solution of 5% Donkey Serum, 2 % Bovine Serum 
Albumin, 0.1% Tween-20, 0.1% Triton-X-100 for 2 hours at RT in a humidity chamber. Slides 
were immunolabeled using monoclonal mouse anti-rabbit CD31 (1:50) (Thermo Fisher Scientific, 
Waltham, MA), an indicator for angiogenesis via endothelial cells overnight at 4C. After PBS 
washes, sections were incubated in a secondary biotinylated anti-mouse IgG (1:200) (Vector, 
Burlingame, CA) for 30 minutes at RT followed by incubation in Vectastain Elite Avidin/Biotin 
Complex (ABC) Reagent (Vector, Burlingame, CA) for 30 minutes at RT. Tissue section were 
then incubated with DAB (3,3’-diaminobenzidine) HRP substrate until dark brown reaction was 
visible. Vector Hematoxylin QS was used to counterstain the nuclei followed by a dehydrated 
series of alcohols and mounting coverslips for imaging. Images of 5 to 7 single mesh fibers per 
sample were taken at 40X objective for CD31+ immunolabeling on Nikon Eclipse 50i (Nikon, 
Tokyo, Japan). 
Blood vessels were identified as positively immunolabeled endothelial cells 
morphologically representing a lumen and vessel counts were measured based on an adapted 
Weidner’s method [78]. Each image was overlaid with a 19x14 grid (650 um2 with 266 total points) 
in Fiji image processing software (National Institutes of Health, Bethesda, MD) (Figure 12).  The 
intersection of the superimposed grid points with a blood vessel was counted and allowed to take 
vessel size into consideration into the final result. Using this count and the total tissue area 
measured as the area of the 20X field subtracted by the area of the mesh fiber, a vessels/area value 
was calculated for each image. The mean and standard error of the mean was respectively 
calculated for each sample.  
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Figure 12: Example of a mesh fiber labeled with CD31 and utilizing Fiji image processing software to display 
a counted image shown with grid overlay 
 
 
 Verhoeff’s Van Gieson (Elastin) 
Vaginal tissue sections were stained with Verhoeff’s van Gieson Elastic Stain kit (Sigma 
Aldrich, St. Louis, MO) to observe the appearance of elastic fibers throughout vaginal tissue. 
Sections were submerged in a Working Elastic Stain Solution for 10 minutes, with subsequent 
rinsing, followed by differentiating steps in Ferric Chloride solution for 1 minute. Sections were 
immersed in a Van Gieson counterstain for 2 minutes. Representative images per sample were 
taken at 20X and 40X field to observe the presence and type of fragmentation of elastic fibers 
throughout tissues on Nikon Eclipse 50i (Nikon, Tokyo Japan).  
 33 
 Biochemical Components (MMP Activity, Elastin, Collagen, sGAG) 
6.2.10.1 Protein Extractions 
All tissue samples were homogenized in a High Salt Buffer (pH 7.5, 50 mM Tris base, 150 
mM NaCl, 5 M CaCl2, 1% Triton-X-100, 0.01 % Halt protease inhibitor cocktail, Pierce 
Biotechnology, Rockford, IL). Protein concentrations were quantified using the BCA Protein 
Assay Kit (Pierce Biotechnology, Rockford, IL) following the manufacturer’s instructions.  
6.2.10.2 MMP Activity Assay 
MMP assay was adapted from the EnzChek Gelatinase/Collagenase protocol (Molecular 
Probes, Inc., Eugene, OR). 10 µg of protein for each sample was used. Samples were incubated 
with 1X Reaction buffer (diluted from 10X 0.5M Tris-HCl, 1.5 M NaCl, 50 mM CaCl2, 2 mM 
sodium azide, pH 7.6) followed by addition of DQ gelatin from porcine skin (100 µg/mL) at room 
temperature. The fluorescence intensity was read at an excitation of 495 nm and an emission at 
515 nm after 1 hour of incubation and 16 hours of incubation.  MMP values are calculated using 
Type IV collagenase/gelatinase standards where one unit of gelatinase A is defined as the amount 
that can hydrolyze 1 mg of type IV collagen within one hour at 37C, pH 7.5. The 16-hour 
incubation time point was optimized for use due to the increased sensitivity in measurements.  
6.2.10.3 Ninhydrin Assay (Insoluble Elastin Quantification) 
Vaginal control and vaginal mesh protein extracts were hydrolyzed in 0.1 M NaOH at 98C 
for 1 hour. This was then followed by centrifugation and washing steps that separated the insoluble 
elastin. Samples were incubated in 6N HCl at 110C for 24 hours followed by a 2-hour cycle in a 
speed vacuum until samples were completely dry. In order to run the Ninhydrin assay, samples 
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were incubated with a working reagent consisting of stannous chloride and Ninhydrin reagent for 
1 hour at 56C in a water bath. The optical density was determined at a wavelength of 570 nm. 
Elastin content was quantified through the calculations from a known standard curve.   
6.2.10.4 Hydroxyproline Assay (Collagen Quantification) 
10 mg of each frozen sample was digested in a papain solution (0.01 M L-cysteine (Sigma, 
St. Louis, MO), 0.125 mg/mL Papain Type III from papaya latex (Sigma, St. Louis, MO), 
Phosphate Buffer (0.1 M Na2HPO4, 0.01 M Na2EDTA, pH 6.5) at 60C in a water bath for 16 
hours. Samples were further hydrolyzed in 2N NaOH at 100C on a heating block for 12 hours. 
This was followed by the addition of 5N HCl, 0.01 M CuSO4, 2.5 N NaOH, and 6% H2O2. Samples 
were then placed on a heat block at 80C for 5 minutes and cooled. 3N H2SO4 was added to each 
sample as well as 5% p-dimethylaminobenzyladehyde in n-propanol followed by incubation at 70C 
on a heat block for 15 minutes. The absorbance was read at 540 nm. Collagen content was 
quantified with the knowledge that hydroxyproline is estimated to consist of 13 – 14% of total 
collagen [79, 80]. 
6.2.10.5 Glycosaminoglycan Assay (GAG Quantification) 
10 mg of each frozen sample was digested in a papain solution (0.01 M L-cysteine (Sigma, 
St. Louis, MO), 0.125 mg/mL Papain Type III from papaya latex (Sigma, St. Louis, MO), 
Phosphate Buffer (0.1 M Na2HPO4, 0.01 M Na2EDTA, pH 6.5) at 60C in a water bath for 16 
hours. Samples and a Chondroitin-6-sulfate from shark cartilage (Sigma, St. Louis, MO) serially 
diluted standard were incubated with a 1,9-Dimethylmethylene Blue dye and the optical density 
was read at a wavelength of 525 nm.  
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 Ball Burst Mechanical Testing 
Vaginal mesh samples preserved in saline were used for ball burst testing to determine 
structural properties of the vaginal tissue post-implantation. Polypropylene mesh (n = 5) was tested 
alone to allow for comparison of mesh properties and for later calculations on determining tissue 
contributions. Mesh was placed between two metal clamps that was screwed into the apparatus 
setup on an Instron TM 4502 (Instron, Norwood, MA) (Figure 13). At the top was a stainless-steel 
ball rod designed to push through a hole in the clamps. The ball rod diameter measured to be 9.52 
mm with a surface area of 216 mm2 as scaled previously using the American Society of Testing 
and Materials (ASTM) standards [81].  This ball was attached to a load cell, which can produce 
up to 5 kN of load.  
The ball rod was centered and lowered against each clamped sample at a constant rate of 
10 mm/min to a 0.5 N pre-load. Then, each sample was loaded to failure at a rate of 10 mm/min.  
The failure load (N) and elongation (mm) data are then utilized to create load-elongation 
curves to determine the structural properties. Stiffness (N/mm) was calculated as the maximum 
slope of the over 20% of the failure elongation. Energy absorbed was calculated as the area 




Figure 13: Instron Set up for Ball Burst Testing 
 37 
 




 Statistical Analysis 
Based on previous studies, a sample size of 5 animals were deemed sufficient for 
determining statistical differences between groups in the analysis [73]. Descriptive statistical 
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analysis was done to determine normality using Kolmogorov-Smirnov and Shapiro-Wilk tests with 
alpha = 0.05. Immunolabeling data for each anatomical location at both acute and chronic time 
points were assessed using one-way analysis of variance with Tukey post hoc test with p<0.05 
used to determine significance. Independent samples t-tests were used to determine differences 
based solely on anatomical location.  
6.3 Results & Discussions 
 Surgical Outcomes  
A total of 12 nulliparous New Zealand White Rabbits were used in this study. Rabbits were 
randomly assigned to be split into two groups (n = 7 for 14 days and n = 5 for 90 days). One animal 
in the study experienced an abdominal hernia where a portion of the intestinal tract pushed through 
the abdominal muscle wall. However, the hernia was repaired and the overall animal health was 
not impacted. Two other animals in the study experienced dehiscence of the skin, but those were 
also immediately repaired and were far from implant location.   
At the time of necropsy, all rabbits were observed for presence of adhesions or any internal 
deviations. At both 14 and 90 days, there was noticeable scar tissue surrounding the subcutaneous 
implant location that is characteristic of a normal response to a material. Upon opening inside the 
peritoneal cavity, there were adhesions formed by the peritoneal mesothelium between the internal 
organs, indicative of an active response to the mesh and the surgery itself [82]. The 14-day implants 
were easier to dissect away from the surrounding tissues than the 90-day implants. This aligns with 
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the expected differences upon comparing the acute and chronic responses, where stronger 
adhesions indicate increased time for the fibrinous gel matrix to develop [82]. 
 Histological Analysis Tissue Morphology 
Post-implantation evaluation showed all animals elicited an immune response at 14 days 
which persisted at 90 days. This is consistent with the host response to mesh seen in other animal 
models observing multiple time points[44, 50, 62, 75, 77]. Histological analysis revealed a 
mononuclear cell population surrounding mesh fibers followed by the presence of a few foreign 
body giant cells in some cases (Figure 16). Interestingly, there was an increased presence of 
eosinophils (Figure 15) found distributed throughout both the subcutaneous and vaginal tissues. 
Eosinophils are known to be present in the process of wound healing and allergic inflammation, 
however there is little known on the significance of eosinophil presence long-term. Nevertheless, 
researchers have previously found a relationship between eosinophils and the metabolism of 
collagen [83]. Eosinophils can be identified by the purple nucleus and perfectly round cytoplasmic 







Figure 15: Distribution of eosinophils observed throughout the tissues in mesh host response. Scale bar shown 
as 50 µm. 
 
 
Overall, a foreign body response to mesh indicative of inflammation both at acute and 
chronic time points was observed both in the subcutaneous and vaginal implants, but heightened 
for the vaginal implants as observed through quantification and analyses. This corresponds to 
previous work in discovering tissue degradation and chronic inflammation with the implantation 
of mesh[33, 34, 50, 69]. The distinct biological processes of the cell response, collagen deposition, 
immune cell presence, vascularity, elastic fiber presence, and other factors will be discussed in 
detail in further sections.  
 Cellularity Quantitative Analysis 
Total cell response showed differences based on anatomical location at 90 days with 
subcutaneous implantation showing a 22 % increase compared to vaginal implants (p = 0.0030) 
(Figure 17). However, vaginal implants showed 46 % less in cellularity from 14 days of 
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implantation to 90 days of implantation (p = 0.0043) (Figure 17). This indicates that the 
subcutaneous implants encouraged a higher cellular infiltration count when compared to the 
vaginal implants. While cellular infiltration is the beginning of understanding the host response, 
further analysis on the characteristics of these cells provides more information on how the response 





Figure 16: H&E Analysis. Representative hematoxylin and eosin stained images of single mesh fibers 
implanted both subcutaneously and vaginally at 14 and 90 days. Control tissues refer to native abdominal 


















14 Days 90 Days Control 
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Figure 17: Cellularity analysis of subcutaneous and vaginal tissues at both 14- and 90-days post-implantation 
of mesh [C]. Comparisons are made to control tissues consisting of native vaginal tissue  [A] and native 





 Collagen Quantitative Analysis 
Both subcutaneous and vaginal implants formed fibrotic capsules surrounding mesh fibers, 
however, both showed significant differences in collagen formation between 14- and 90-days 
indicative of scar tissue.  At 14-days post-implantation, loose collagen fibers were observed to be 
dispersed in the fibrous connective tissue (Figure 18) considered to be typical during the early host 
response. At 90-days post-implantation, however, both implants depicted denser collagen fibers 
surrounding the implants (Figure 19) with the presence of looser fibers farther distances away from 
mesh fibers. Subcutaneous implants showed a 1.6- fold increase in % collagen from 14 days to the 
90-day mesh implants (p = 0.0171). Vaginal implants increased 1.91-fold in % collagen area at 90 
days as compared to the early response (p = 0.0028). At both locations, marked thicker collagen 
fibers were observed surrounding mesh fibers by 90 days as compared to 14 days.  Picrosirius 
staining depicted changes in collagen fiber thickness surrounding mesh implants, with both 
locations increasing in thicker collagen fibers (p < 0.0001) by 90 days (Figure 20). Overall, 
increased collagen deposition in vaginal explants further supports that the vaginal explants have a 
significantly higher inflammatory reaction overall. The increased collagen suggests processes of 
fibrotic development as time progresses, which is observed with the shifts in the two time points 




Figure 18: Representative Masson’s Trichrome stained images of single mesh fibers implanted both 
subcutaneously and vaginally at 14 and 90 days compared to native vaginal tissues and native abdominal 
muscle controls. Collagen is depicted in blue; Muscle is shown 
 
The results of this study presented an interesting trend with increased collagen deposition 
around vaginal explants, most significantly at 90 days post-implantation. Increased collagen 
deposition in vaginal explants further supports that the vaginal explants have a significantly higher 
inflammatory reaction overall. The increased collagen suggests processes of fibrotic development 
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Figure 19: Trichrome analysis of subcutaneous and vaginal tissues at both 14- and 90-days post-implantation 
of mesh. Comparisons are made to control tissues consisting of native vaginal tissue and native abdominal 

















































Figure 20: Picrosirius Red Analysis: Representative Picrosirius Red stained images of single mesh fibers 
implanted both subcutaneously and vaginally at 14 and 90 days shown under polarized light. All scale bars 















































































*     p < 0.05
**    p < 0.005
***   p < 0.001
**** p < 0.0001
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 Elastin Qualitative Analysis 
The appearance of elastic fibers changed drastically from the control tissue (native vagina) 
to tissue with mesh implanted. Histologically, native vaginal tissue depicts thick black continuous 
elastic fibers (Figure 21A & 21B). However, the changes in appearance at 14 days post-
implantation of mesh are distinctive as the elastic fibers completely fragment or appear to remodel. 
There are noticeable differences in the context of the surrounding connective tissue alignment with 
these elastic fibers and mesh fibers. At 14 days post-implantation, single layers of fragmented 
elastic fibers (Figure 21C & 21D) were observed in the same area of tissue remodeling surround 
mesh fibers. Conversely, the vaginal implants at 90 days post-implantation had limited, if any 
elastin that could be found throughout the tissues (Figure 22). 
A unique finding in this study was the appearance of elastic fibers at 14 days post-
implantation in the vaginal explants. In the native vagina, elastin composes 13 % of the total organ, 
mostly in the muscularis along the vaginal wall [68, 85]. Elastin is a key structural component, 
responsible for the resilience and elasticity of tissues [86]. Little is known of elastic remodeling in 
the vagina compared to other organs in the body, however, it has previously been found that elastin 
metabolism is altered in the vagina in rodent models of prolapse and as opposed to other organs in 
the body is capable of remodeling over the reproductive lifespan [85]. A recent study demonstrated 
that polypropylene mesh negatively impacts rabbit vaginal morphology and function, specifically 
in the context of smooth muscle degradation[87]. Other studies have shown that degradation of 
the vaginal wall occurs as a result of a decreased mechanical load with the use of mesh, otherwise 
known as stress shielding [35, 79]. Verhoeff’s van Gieson staining allows for demonstration in 
changes of elastic fibers, such as thinning and loss related to the atrophy of elastic tissue. The 
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findings at 90 days indicate that the elastin may have degraded completely or become so 





Figure 21: Elastin in the Native Vagina vs. Elastin implanted via Lumbar Colpopexy at 14 Days. A. Native 
vaginal tissue in a 10X field stained with Verhoeff’s van Gieson. Arrow indicates elastic fibers in tissue. B. 













Figure 22: Representative image of vaginal tissue stained with Verhoeff’s van Gieson at 90 Days depicting 
fragmented elastic fibers 
 
 
 Angiogenic Analysis 
At 14 days post-implantation, both subcutaneous and vaginal explants histologically 
showed the presence of blood vessels surrounding individual mesh fibers (Figure 23). Utilizing an 
endothelial cell marker (monoclonal mouse anti-CD31) widely used to label cells lining blood 
vessels, the subcutaneous implants did not depict any significant differences in the number of 
vessels observed per area surrounding each fiber. However, the vaginal implants increased by 
almost two-fold in the number of vessels per area by 90 days of implantation from 14 days (p = 
0.0134) (Figure 23). This is consistent with the immune response related to cases where the tissue 
is considered hypoxic and angiogenic factors are increased, thus the presence of blood vessels 
overall is found to be increased. However, the vaginal tissue is complex and there can be a variety 
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of factors related to the vaginal microenvironment, such as macrophage cues, that may have 
resulted in this increase in vascularity.  
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Figure 23: Representative images of CD31+ immunolabeling of mesh fibers both subcutaneous and vaginal at 

















 Macrophage Analysis 
Vaginal implants elicited an overall increased host inflammatory response as compared to 
the subcutaneous implants (Figure 24). Interestingly, 37% of the total cell population was positive 
for macrophages at 14 days, with the macrophage response persisting at 90 days consisting of 53% 
of the total cell population (p = 0.0057). Comparatively, at 14 days post-implantation, 14% of the 
total cell population consisted of macrophages in the subcutaneous implants with a persistent 
response at 90 days comprising of 24 % of the total cell population (p = 0.35) (Figure 24).  
It is especially interesting to consider the increased host macrophage response observed in 
vaginal implants as the total cellular response to mesh remained consistent across anatomical 
location. There was an initial increase at 14 days observed in both sites of implantation followed 
by a decrease at the later time point of 90 days. However, the macrophage presence was not 
proportional to the cellular density. This suggests that the increased macrophage presence in the 
vaginal mesh-tissue explants was due to an increased inflammatory response, where majority of 
the cell population were macrophages surrounding mesh fibers as opposed to an increased 
proportion due to a change in location of implantation. In fact, there was even a decrease in 
cellularity observed at 90 days in the vaginal implants as compared to the subcutaneous implants 
at 90 days.  
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Figure 24: Macrophage Analysis: Representative images of RAM11+ immunolabeling of mesh fibers both 
subcutaneous and vaginal at 14- and 90-days post-implantation. All scale bars are 50 µm. Data is shown as 




















Most interestingly, the vaginal mesh-tissue implants elicited an inflammatory response at 
14 days post-implantation that persisted at 90 days as noted by the macrophage presence 
surrounding mesh fibers. By contrast, the subcutaneous tissue implants showed a decreased 
macrophage presence, although a mild reaction was observed. However, the trend of an initial 
acute foreign body response observed at 14 days post-implantation followed by a reduced, but 
persistent inflammatory response observed at 90 days post-implantation for all mesh-tissue 
implants is a consistent trend with the implantation of any synthetic material. This is similar to 
what is seen in other animal models implanted with mesh including mice implanted 
subcutaneously [50] and rhesus macaques implanted via sacrocolpopexy[33, 88].  
 Biochemical Components 
In order to assess the matrix-metalloproteinase (MMP) levels in vaginal tissues, a 
gelatinase substrate degradation assay was performed to measure gelatinase activity. It is well 
known that MMPs are associated with tissue matrix degradation and has even been found to be 
upregulated in the vagina in women with prolapse [89]. Interestingly, we found no significant 
differences in MMP activity between the vaginal control (3.06 ± 1.41 units/mg protein) and vaginal 
implants at 14 days after implantation (3.67 ± 1.72 units/mg protein). However, there was a 
significant increase in activity at 90 days post-implantation (18.96 ± 5.60 units/mg protein, p < 




Figure 25: Gelatinase Activity comparing pristine mesh vaginal implants at 14 days and 90 days post 
implantation with native vaginal control tissues. Data shown as values ± SEM. 
 
In order to further assess the elastin content in the vaginal tissues, a ninhydrin assay was 
performed using protein extracts. Interestingly, we found a high amount of elastin in the vaginal 
control samples (73.22 ± 7.07 elastin percentage (µg elastin/mg total protein)). However, after 14 
days post-implantation, samples had significantly decreased amount of elastin (28.26 ± 11.36 
elastin percentage (µg elastin/mg total protein), p = 0.0019) compared to the vaginal control 
samples. Additionally, after 90 days post-implantation, vaginal implants were not significantly 
different in elastin percentage than at 14 days but still significantly different than the vaginal 
control (25.35 ± 6.34 elastin percentage (µg elastin/mg total protein), p = 0.0002). This provides 
for an interesting case of characterizing changes in elastin observed histologically and now in 
protein biochemistry.  
 56 
 
Figure 26: Elastin Content comparing pristine mesh vaginal implants at 14 days and 90 days post-
implantation with native vaginal tissues. Data shown as values ± SEM. 
 
In order to further quantify the hydroxyproline content found in the explanted tissues, a 
hydroxyproline assay was performed. While there was an overall increase in concentration for the 
vaginal samples compared to the subcutaneous samples, there were no significant differences 
found between groups that were found between the 14 day and 90-day times of implantation. 
Additionally, a glycosaminoglycan assay was performed, however, the concentrations were found 
to be relatively low and thus difficult to observe differences between groups.  
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Figure 27: Hydroxyproline content comparing native abdominal muscle control and native vaginal control to 
pristine mesh implants both subcutaneously and vaginally at both 14 and 90 days 
 
 
Figure 28: Glycosaminoglycan content comparing native abdominal muscle control and native vaginal 
control to pristine mesh implants both subcutaneously and vaginally at both 14 and 90 days 












































































 Ball Burst Mechanical Testing Outcomes 
In order to estimate the individual vaginal mechanical properties, specifically related to 
structural integrity, we performed ball-burst mechanical tests on the mesh-tissue complexes both 
at 14- and 90-days post-implantation. This is then followed with the assumption that by calculating 
the stiffness of the mesh by itself, we can subtract that value from the determined stiffness of the 
complex to estimate the vaginal tissue stiffness. It has been previously shown that the innate 
structural properties of polypropylene mesh remain stable over time [81]. Thus, by determining 
the structural properties of the mesh and the structural properties of the mesh-tissue complexes 
will allow for us to determine the structural properties of the tissue by assuming that the stiffness 
of the mesh plus the stiffness of the tissue totals the stiffness of the mesh-tissue complex. There 
were no significant differences observed in the estimated vaginal tissue contribution calculated at 
14 days post-implantation and 90 days post-implantation. However, in both cases, the estimated 
stiffness was very low as compared to what has been previously seen in other animals implanted 




Figure 29: Representative Load-Extension curves from Ball-Burst tests of Gynemesh, Vaginal mesh-tissue 
complex at 14 days post-implantation, and Vaginal mesh-tissue complex at 90 days post-implantation 
 
 
Figure 30: A. Load at Failure for pristine mesh implants at 14- and 90-days post-implantation B. Stiffness of 
mesh-tissue complex at 14- and 90-days post-implantation C. Estimated stiffness of vaginal contribution for 
pristine mesh implants at 14- and 90-days pos 
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A rabbit model of pelvic reconstruction provides the ability to implant mesh via lumbar 
colpopexy and to examine the host inflammatory and remodeling response at acute and chronic 
time points. The overall purpose of this aim was to identify significant differences in the immune 
and tissue remodeling response dependent upon anatomical location of implantation, suggesting 
that results of subcutaneous implantation studies are not a reliable predictor of performance when 
implanted into the vagina. This underscores the importance of developing a full understanding of 
the tissue-specific microenvironment of pelvic floor repair. Results from this aim contribute to the 
overarching data previously reported following the implantation of mesh in a variety of animal 
models and anatomical locations. Overall, this suggests that the rabbit may offer a more cost-
effective alternative while still allowing a clinically relevant implantation.  
We found distinct host responses to polypropylene mesh implanted in two different 
anatomical locations.  In a model of pelvic reconstructive surgery, mesh was implanted onto the 
vagina and tensioned to the spine via lumbar colpopexy. A common surgical model of 
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subcutaneous implantation of mesh was used for comparison as an assessment of the host response 
to mesh in the abdominal wall. The overall aim of the study was to describe the host response to 
mesh post-implantation in each of these locations with the distinct perspective of understanding 
the response at early and late time points. We found significant differences in the development of 
the inflammatory response to polypropylene prolapse mesh, with respect to the presence of 
macrophages, the collagen fibrotic capsule formation, elastic fiber changes, and vascularity.   
Overall the host response to the same material implanted vaginally versus subcutaneously was 









7.0 Aim 2: To Scale Up the Controlled Release of IL-4 from a Layer-by-layer Coating 
Immunomodulatory Strategy to Improve Downstream Outcomes Following Mesh 
Implantation 
7.1 Introduction 
The findings from the previous aim confirm the presence of an inflammatory response to 
mesh at both acute and chronic time points, with indications of tissue degradation, poor remodeling 
outcomes, and unresolved inflammation. As a consequence, the purpose of this study involves the 
scale up of an immunomodulatory strategy to directly affect the response to mesh in a clinically 
relevant model at both acute and chronic time points.  
There has been much work in the field of immunomodulation that demonstrates improved 
tissue remodeling outcomes associated with a shift from a pro-inflammatory profile to a more anti-
inflammatory profile [44, 50, 52, 55]. This is particularly evident when this shift occurs during the 
earlier stages of the inflammatory response to a biomaterial. Specifically, an IL-4 eluting coated 
mesh developed previously for a mouse subcutaneous model of implantation has shown great 
success in promoting a dominant M2 anti-inflammatory macrophage response and was found to 
be associated with decreased fibrotic capsule deposition while showcasing improved mesh-tissue 
integration [50]. However, the success of this work has been limited to utilizing mesh proportional 
to the size of the rodent model along with a limited mode of implantation. In order to contribute to 
the field and further the knowledge on modulating the host response, the second aim focuses on 
scaling the IL-4 eluting coating to a larger animal model and utilizing a clinically significant 
surgical model. Thus, paired with the development and utilization of the clinically relevant model 
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of lumbar colpopexy from Aim 1, this subsequent aim intends to incorporate a cytokine release 
system onto the polypropylene mesh with the goal of promoting a positive regenerative outcome.  
7.2 Materials & Methods 
 Plasma Irradiation Treatment  
 
Figure 31: Schematic of the plasma irradiation process 
 
 
The surface of polypropylene mesh was exposed to an adapted radio frequency glow 
discharge method to create a stable negative charge preparing for further coating procedures.  
Large (3 x 12 cm2) and small (1x1 cm2) pieces of mesh were cleaned by immersion into a 1:1 
solution of isopropanol and acetone followed by sonication for 1 minute and air dried. Mesh was 
then exposed to one minute of Argon plasma at a flow rate of 35 mL/min, 600 W (2.45 GHz 
frequency) and steady state pressure (250 – 285 mTorr) in an Ion 40 Gas Plasma System (PVA 











anhydride was crushed into a powder via mortar and pestle and carefully distributed in a glass dish. 
The glass dish with the maleic anhydride and mesh pieces spaced 8 – 8.5 cm apart were placed 
into the Ion 40 Gas Plasma chamber on a tray with electrodes connected to the ground (Figure 33).  
a. Argon gas flow rate: 35 mL/min  
b. RF Power Generator: 600 W (2.45 Ghz frequency)  
c. Steady State Pressure: 250 – 285 mTorr 




Figure 32: Ion Gas Plasma System Machine interface 
 
 
Figure 33: Set up of tray orientation inside plasma chamber 
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A vacuum was created inside the chamber by reaching a pressure of 50 mTorr or lower, 
followed by exposure to plasma irradiation for 1 minute at an Argon gas flow of 35 mL/min, 600W 
(2.45 GHz frequency), and a steady state pressure (250 – 285 mTorr). Mesh was then hydrolyzed 
in Type I H2O for 30 minutes and boiled for 20 minutes.    
 Scale Up of Layer-by-Layer Coating 
The polypropylene mesh was immersed in alternating polycationic and polyanionic 
solutions to create 50 bilayers in total, with one bilayer being defined as one set of consequential 
polycationic and polyanionic dips. This was achieved utilizing a custom MTI SILAR Automated 
Dip Coated machine (Figure 34) (8 – position SILAR coating system, PTL-SC-6A, MTI 
Corporation, Richmond, CA). Chitosan (Sigma, St. Louis, MO) was dissolved in 0.5 % acetic acid 
at a concentration of 2 mg/mL and used for each polycationic layer. Dermatan sulfate (Sigma, St. 
Louis, MO) was dissolved in Type I water at a concentration of 2 mg/mL and used for each 
polyanionic layer. For each alternating polycationic polymer and polyanionic polymer solution, 
the mesh was immersed for 10 minutes each, interspersed with a brief air-drying period. After each 
bilayer was formed, the mesh was washed three times in Type I water for one minute and air dried 
before the next immersion step. A core coating consisting of 10 bilayers of each polymer was 
formed on each piece of mesh. In order to incorporate cytokine release, recombinant rabbit IL-4 
(R&D Systems, Minneapolis, MN) at a concentration of 1.5 µg/mL was complexed with a 2 
mg/mL solution of dermatan sulfate for at least 18 hours at 4°C. Mesh was subsequently dipped 
in chitosan and IL-4 complexed dermatan sulfate solutions for 40 bilayers total. Once completed, 
mesh was terminally sterilized using ethylene oxide and stored at -20°C.  
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Figure 34: MTI SILAR Automated Dip Coating machine used for layer-by-layer coating 
 
 Scale Up Cytokine Bioactivity 
A controlled release assay was used to determine the release profile of the IL-4. Briefly, 5 
different 1x1 cm2 pieces of coated mesh were sampled from different locations on a large 3x12 
cm2 piece (See schematic) Each mesh was submerged in release media (1X phosphate buffered 
saline consisting of 0.05 U/mL chitosanase (Sigma, St. Louis, MO) and 0.05 U/mL chondroitinase 
ABC (Sigma, St. Louis, MO) at 37°C. The solution was sampled and replaced with fresh release 
media at periodic intervals until IL-4 had finished eluting. Each sampled solution was measured 
via enzyme linked immunosorbent assay (ELISA) for quantification of IL-4 concentration (Rabbit 
IL-4 ELISA, R&D Systems, Minneapolis, MN).  
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 Isolation of Rabbit Peripheral Blood-Derived Macrophages 
Peripheral blood was collected from the New Zealand White Rabbit ear vein and placed 
directly into heparinized blood tubes for further processing. Each sample was diluted 1:1 in Hank’s 
balanced salt buffer no calcium, no magnesium (Thermofisher, Waltham, MA) followed by the 
addition of Ficoll-Paque PLUS solution according to manufacturer’s instructions on proportions 
(Fisher Scientific, Hampton, NH). The mononuclear cell layer (Figure 35) was isolated and cells 
were resuspended in macrophage culture media (RPMI 1640, 10% FBS, 1% PenStrep, 1% HEPES 




Figure 35: Isolation of mononuclear cell layer using Ficoll-Paque separation technique 
 
 Isolation of Rabbit Bone Marrow-Derived Macrophages 
Bone marrow-derived macrophages were collected from the femurs and tibia of New 
Zealand white rabbits at the time of necropsy. The skin, muscle, and connective tissue was 
removed to isolate the femur and tibia of each rabbit. Bones were then moved into a sterile 




Plasma Blood Sample 
Ficoll-Paque 
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cavity was flushed with a needle and syringe filled with macrophage culture media (RPMI 1640, 
10% FBS, 1% PenStrep, 1% HEPES Buffer, 2 % Non-essential Amino Acids, and 20 ng/mL 
Rabbit GM-CSF). Followed by a series of subsequent centrifugation and filtration steps, bone 




Figure 36: Image of a tibia isolated from the New Zealand White Rabbit 
 
 In vitro Macrophage Rabbit Macrophage Polarization 
Rabbit macrophages obtained from either method of isolation (peripheral blood vs. bone-
marrow lysate) were plated at a concentration of 1 x 106 cells/mL and cultured for 7 days at 37°C, 
5% CO2 with the addition of macrophage media at 2 intervals. Macrophages were then treated 
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with polarizing cytokines for 24 hours to culture three distinct phenotypic differentiations. M0 
macrophages were cultured in traditional macrophage media and served as naïve controls. M1 pro-
inflammatory macrophages were cultured with 20 ng/mL recombinant rabbit interferon gamma 
(IFN- γ) (Abcam, Cambridge, United Kingdom) and 100 ng/mL lipopolysaccharide (LPS) from 
Escherichia coli supplemented in macrophage media (RPMI 1640, 10% FBS, 1% PenStrep, 1% 
HEPES Buffer, 2 % Non-essential Amino Acids, and 20 ng/mL Rabbit GM-CSF). M2 anti-
inflammatory macrophages were cultured with 20 ng/mL of recombinant rabbit interleukin-4 
(R&D Systems, Minneapolis, MN) supplemented in macrophage media (RPMI 1640, 10% FBS, 
1% PenStrep, 1% HEPES Buffer, 2 % Non-essential Amino Acids, and 20 ng/mL Rabbit GM-
CSF).  
 Macrophage Immunolabeling  
After macrophage polarization, the supernatant was aspirated and saved for other 
functional assays. Macrophages were then fixed with 2% paraformaldehyde (PFA) for 30 minutes. 
Macrophages were then washed in 1X phosphate buffered saline followed by incubation in 
blocking solution (2% donkey serum, 1% bovine serum albumin, 0.1% Tween-20, 0.1% Triton X-
100) for 1 hour. Macrophages were immunolabeled with monoclonal mouse anti-rabbit RAM11 
(1:200) (Dako North America, Inc. Carpinteria, CA) overnight at 4°C. After washing with 1X 
phosphate buffered saline, macrophages were then incubated with the secondary antibody, donkey 
anti-mouse Alexa Fluor 594 (1:200) (Abcam, Cambridge, United Kingdom) for 1 hour. 
Macrophages were counterstained with 4’,6-diamidino-2-phenylindole (DAPI) (BioLegend, San 
Diego, California) to label nuclei. At least 3 – 5 images of each well were taken in a 10X and 20X 
field using a Nikon TE-2000-E inverted microscope in TRITC and DAPI channels.  
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 Functional Assays: Nitric Oxide Production 
The supernatants collected from the previous macrophage polarization cultures were used 
for the Nitric Oxide Greiss Reagent System Assay (Promega, Madison, WI). Briefly, supernatants 
were incubated with 1% sulfanilamide in 5% phosphoric acid in the dark at room temperature for 
10 minutes. This was followed by the addition of 0.1% N-1-napthylethylenediamine 
dihydrochloride in Type I water for 10 minutes at room temperature in the dark. The absorbance 
was read at a wavelength 540 nm and compared to a sodium nitrite standard curve.  
 Functional Assays: Arginase Activity  
Macrophages following polarization procedure were lysed using a lysis buffer (0.001% 
Triton X-100, 0.01% Halt Protease Inhibitor in Type I water). An arginase activation solution (10 
mM MnCl2, 50 mM Tris-HCl in Type I water, pH 7.5) was added to cell lysates and incubated for 
10 minutes at 55°C. An arginine substrate solution (0.5 M L-arginine in Type I water, pH 9.7) was 
added to the activated samples and incubated at 37°C for 2 hours and 24 hours. At 2 hours and at 
24 hours of incubation, 5 uL of each sample and standard was taken into a new 96-well plate 
followed by the addition of urea detection solution (0.03% Brij35, 2.5 M Sulfuric Acid, 2.5 g/L 
Boric Acid, 100 mg/L Phthalaldehyde, 513 mg/L Primaquine). The absorbance was measured at a 
wavelength of 430 nm at 10 minutes and 20 minutes of incubation and compared to a urea standard.  
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 RNA Extraction and Pro-Inflammatory/Anti-Inflammatory Gene Expression 
Following manufacturer’s instructions, total RNA of polarized macrophages was extracted 
using RNeasy Miniprep RNA Isolation kit (Qiagen, Valencia, CA). RNA concentration and purity 
were determined using a NanoDrop Lite Spectrophotometer.  
Isolated RNA was reverse-transcribed to create cDNA templates using a High Capacity 
RNA-to-cDNA kit (ThermoFisher Scientific, Waltham, MA) and following the manufacturer’s 
instructions.  Taqman Gene Expression Assays (ThermoFisher Scientific, Waltham, MA) were 
performed for the following pro-inflammatory and anti-inflammatory panel of markers (See Table 
3). Gene expression was normalized to the housekeeping gene, glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH; Oc03823402_g1). Values were normalized to those obtained from the 
control group (M0, naïve macrophages). 
 
Table 5: Panel of pro-inflammatory and anti-inflammatory markers  
Pro-inflammatory  Anti-inflammatory 
iNOS (Oc04096740_g1)  Arg1 (Oc03397217_m1)  
IFN G (Oc04096817_m1)  IL10 (Oc03396940_m1)  
IL6 (Oc04097053_m1)  TGFB 1 (Oc04176122_u1)  




 Cytokine Bioactivity Assays 
A series of in vitro macrophage cultures was also used to test the bioactivity of IL-4 
incorporated into the coating on the mesh. Pristine mesh, polymer-only coated mesh, and IL-4 
coated mesh were incubated with previously cultured macrophages for 24 hours with culture media 
(RPMI 1640, 10% FBS, 1% PenStrep, 1% HEPES Buffer, 2 % Non-essential Amino Acids) 
supplemented with 0.05 U/mL chitosanase (Sigma, St. Louis, MO) and 0.05 U/mL chondroitinase 
ABC (Sigma, St. Louis, MO). Concurrent cultures of macrophages were treated with polarizing 
cytokines for 24 hours culture three distinct phenotypic differentiations were used as comparison. 
M0 macrophages were cultured in traditional macrophage media and served as naïve controls. M1 
pro-inflammatory macrophages were cultured with 20 ng/mL recombinant rabbit interferon 
gamma (IFN- γ) (Abcam, Cambridge, United Kingdom) and 100 ng/mL lipopolysaccharide (LPS) 
from Escherichia coli supplemented in macrophage media (RPMI 1640, 10% FBS, 1% PenStrep, 
1% HEPES Buffer, 2 % Non-essential Amino Acids, and 20 ng/mL Rabbit GM-CSF). M2 anti-
inflammatory macrophages were cultured with 20 ng/mL of recombinant rabbit interleukin-4 
(R&D Systems, Minneapolis, MN) supplemented in macrophage media (RPMI 1640, 10% FBS, 
1% PenStrep, 1% HEPES Buffer, 2 % Non-essential Amino Acids, and 20 ng/mL Rabbit GM-
CSF).  
After 24 hours, all treatment groups were processed identically for macrophage 
immunolabeling, functional assays (nitric oxide assay and arginase activity assay), and gene 
expression as described earlier. 
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 Animal Subjects 
A total of 10 nulliparous New Zealand White Rabbits aged 4 – 6 months (~4 kg) were used 
in this study. Animals were obtained from Covance, Inc. (Princeton, NJ). All animals were housed 
in the Center for Preclinical Studies at the McGowan Institute for Regenerative Medicine (MIRM) 
for at least 7 days prior to the start of any procedure. All animals were examined by staff 
veterinarians and determined to be in good health prior to admission into any study. All animals 
were monitored daily. All procedures were approved by the Institutional Animal Care and Use 
Committee at the University of Pittsburgh.  
Rabbits were kept with fresh bedding and enrichment along with access to food and water 
as directed by National Institutes of Health Animal Care Guidelines for rabbit care. Extra 
enrichment was provided in the form of preferential snacks such as blueberries, pineapple, celery, 
strawberries, grapes and romaine lettuce. The rabbits were exposed to a 12-hour light/dark cycle 
and monitored for signs of distress throughout the study.  
 Surgical Design: Lumbar Colpopexy vs. Subcutaneous  
Rabbits were sedated with acepromazine (1 mg/kg) followed by intramuscular injection of 
ketamine/xylazine (35 mg/kg & 5 mg/kg).  Animals were then incubated and a surgical plane of 
anesthesia was achieved via inhalation of 2% isofluorane.  
A midline longitudinal incision was performed opening the peritoneal space with the 
bowels packed away followed by identification of the uterine horn and reproductive organs (Figure 
2A). A hysterectomy was performed followed by trimming and collection of the proximal vagina 
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of the rabbit to serve as a positive control (Figure 2B). Once the uterus was removed, space was 
dissected along the vaginal wall on both sides between the bladder and the rectum (Figure 3A). 
Two 3 x 12 cm2 pieces of Recombinant IL-4 coated Gynemesh PS (Ethicon, Somerville, NJ) were 
secured with 3-0 PDS suture along the posterior and anterior vaginal walls (Figure 3B). The 
remaining flaps at the top were then attached to a ligament in the lumbar spine with 2-0 PDS 
creating support to the pelvic organs (Figure 4A & 4B). The peritoneal cavity was continuously 
hydrated (Figure 5) and sutured closed with continuous stitching using 3-0 PDS. A 2 x 2 cm2 piece 
of mesh was implanted subcutaneously (Figure 6B) onto the abdominal musculature via 3-0 PDS 
prior to closing the initial abdominal incision in the skin with subcuticular stitches. Post-surgically, 
all animals were monitored closely to ensure full recovery from anesthesia.   
 Post-Operative Care 
Animals were carefully monitored for signs of discomfort (as evidenced by failure to eat, 
drink, or resume normal ambulation and activity). Cefazolin (25 mg/kg), Buprenex (0.02 mg/kg), 
and Ketoprofen (2 mg/kg twice daily as needed) was given via subcutaneous injection for pain for 
3 days postoperative. At the veterinarian’s discretion, the animals were given Ranitidine (2 mg/kg) 
as an antacid in cases of a decreased appetite until normal activity resumed. 
 Tissue Explants and Tissue Processing 
At 14 days and 90 days post-implantation, the animals were sedated with acepromazine (1 
mg/kg) and injected intravenously with sodium pentobarbital (100 mg/kg) for euthanasia. The 
mesh and surrounding tissue were extracted from the rabbit and immediately processed. One 
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portion of a representative mesh-tissue explant (Figure 7A & 7B) was fixed in formalin for at least 
48 hours before paraffin embedding. 7 m sections were used for histological analysis. Another 
portion of the explant was flash frozen and kept in -80°C for biochemical evaluations. A 3x3 cm2 
piece of vaginal-mesh tissue was carefully wrapped in gauze and kept in sterile saline at -20C for 
biomechanical testing.  
 Histological (H&E) Tissue Morphology and Characteristics 
Tissue sections were stained with hematoxylin and eosin to observe key aspects of the host 
response to mesh including tissue organization, degradation and encapsulation. Specifically, tissue 
sections were analyzed with an emphasis regarding mononuclear cellular infiltration near mesh 
fibers, the presence of foreign body giant cells and potential angiogenesis.  Cellularity analysis 
was based on 5 to 7 single mesh fibers imaged per sample at a 40X objective on Nikon Eclipse 50i 
(Nikon, Tokyo, Japan) and using Fiji image processing software (National Institutes of Health, 
Bethesda, MD). 
 Collagen Staining & Quantitative Analysis 
7.2.17.1 Masson’s Trichrome 
Tissue sections stained with Masson’s trichrome were imaged to observe the collagen 
deposition within the implantation site. Briefly, sections were immersed in Bouin’s solution at 
56C for 15 minutes, with subsequent washing steps. Sections were then stained with Weigert’s 
Iron Hematoxylin Working Solution for 5 minutes and lastly immersed in Trichrome AB solution 
(Sigma, St. Louis, MO) for 5 minutes. All analysis of collagen area surrounding mesh fibers was 
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based on 5 to 7 single mesh fibers per sample imaged at 20X objective on Nikon Eclipse 50i 
(Nikon, Tokyo, Japan). Fiji image processing software (National Institutes of Health, Bethesda, 
MD) provided a quantitative assessment of the fibrous capsule thickness surrounding the mesh 
fibers. 
 Macrophage Immunohistochemistry (Peroxidase) 
Sections were deparaffinized and rehydrated in a graded series of alcohols followed by 
antigen retrieval in citric acid buffer (pH 6.0) for 20 minutes at 95C. Sections were then incubated 
in 3% hydrogen peroxide in methanol for 30 minutes at RT to block endogenous peroxidases. 
Tissue sections were blocked in a blocking solution of 5% Donkey Serum, 2 % Bovine Serum 
Albumin, 0.1% Tween-20, 0.1% Triton-X-100 for 2 hours at RT in a humidity chamber. Slides 
were immunolabeled using either monoclonal mouse anti-rabbit RAM11 (1:200) (Dako North 
America, Inc., Carpinteria, CA), a pan-macrophage marker, overnight at 4C. After PBS washes, 
sections were incubated in a secondary biotinylated anti-mouse IgG (1:200) (Vector, Burlingame, 
CA) for 30 minutes at RT followed by incubation in Vectastain Elite Avidin/Biotin Complex 
(ABC) Reagent (Vector, Burlingame, CA) for 30 minutes at RT. Tissue section were then 
incubated with DAB (3,3’-diaminobenzidine) HRP substrate until dark brown reaction was visible. 
Vector Hematoxylin QS was used to counterstain the nuclei followed by a dehydrated series of 
alcohols and mounting coverslips for imaging. Images of 5 to 7 single mesh fibers per sample were 
taken at 40X objective for RAM11 on Nikon Eclipse 50i (Nikon, Tokyo, Japan) and using Fiji 
image processing software (National Institutes of Health, Bethesda, MD). 
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 CD31 Immunohistochemistry & Vessel Analysis 
Sections were deparaffinized and rehydrated in a graded series of alcohols followed by 
antigen retrieval in citric acid buffer (pH 6.0) for 20 minutes at 95C. Sections were then incubated 
in 3% hydrogen peroxide in methanol for 30 minutes at RT to block endogenous peroxidases. 
Tissue sections were blocked in a blocking solution of 5% Donkey Serum, 2 % Bovine Serum 
Albumin, 0.1% Tween-20, 0.1% Triton-X-100 for 2 hours at RT in a humidity chamber. Slides 
were immunolabeled using monoclonal mouse anti-rabbit CD31 (1:50) (Thermo Fisher Scientific, 
Waltham, MA), an indicator for angiogenesis via endothelial cells overnight at 4C. After PBS 
washes, sections were incubated in a secondary biotinylated anti-mouse IgG (1:200) (Vector, 
Burlingame, CA) for 30 minutes at RT followed by incubation in Vectastain Elite Avidin/Biotin 
Complex (ABC) Reagent (Vector, Burlingame, CA) for 30 minutes at RT. Tissue section were 
then incubated with DAB (3,3’-diaminobenzidine) HRP substrate until dark brown reaction was 
visible. Vector Hematoxylin QS was used to counterstain the nuclei followed by a dehydrated 
series of alcohols and mounting coverslips for imaging. Images of 5 to 7 single mesh fibers per 
sample were taken at 40X objective for CD31+ on Nikon Eclipse 50i (Nikon, Tokyo, Japan). 
Blood vessels were identified as positively immunolabeled endothelial cells 
morphologically representing a lumen and vessel counts were measured based on an adapted 
Weidner’s method.46 Each image was overlaid with a 19x14 grid (650 um2 with 266 total points) 
in Fiji image processing software (National Institutes of Health, Bethesda, MD).  The intersection 
of the superimposed grid points with a blood vessel was counted and allowed to take vessel size 
into consideration into the final result. Using this count and the total tissue area measured as the 
area of the 20X field subtracted by the area of the mesh fiber, a vessels/area value was calculated 
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for each image. The mean and standard error of the mean was respectively calculated for each 
sample.  
 Verhoeff’s Van Gieson (Elastin) 
Vaginal tissue sections were stained with Verhoeff’s van Gieson Elastic Stain kit (Sigma 
Aldrich, St. Louis, MO) to observe the nature of elastic fibers throughout vaginal tissue. Sections 
were submerged in a Working Elastic Stain Solution for 10 minutes, with subsequent rinsing, 
followed by differentiating steps in Ferric Chloride solution for 1 minute. Sections were immersed 
in a Van Gieson counterstain for 2 minutes. Representative images per sample were taken to 
observe the presence of elastic fibers throughout tissues on Nikon Eclipse 50i (Nikon, Tokyo 
Japan).  
 RNA Extraction and Pro-Inflammatory/Anti-Inflammatory Gene Expression 
Following manufacturer’s instructions, total RNA of frozen tissues was extracted using 
RNeasy Miniprep RNA Isolation kit (Qiagen, Valencia, CA). RNA concentration and purity were 
determined using a NanoDrop Lite Spectrophotometer. Isolated RNA was reverse-transcribed to 
create cDNA templates using a High Capacity RNA-to-cDNA kit (ThermoFisher Scientific, 
Waltham, MA) and following the manufacturer’s instructions.  Taqman Gene Expression Assays 
(ThermoFisher Scientific, Waltham, MA) were performed for the following pro-inflammatory and 
anti-inflammatory panel of markers and other biochemical components (See Table 5). Gene 
expression was normalized to the housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase 
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(GAPDH; Oc03823402_g1). Values were normalized to those obtained from the respective control 
tissues, native vagina and abdominal muscle.  
 
 
Table 6: Panel of pro- and anti- inflammatory markers and other relevant extracellular matrix components 
Pro-inflammatory Anti-inflammatory 
iNOS (Oc04096740_g1) Arg1 (Oc03397217_m1) 
IFN G (Oc04096817_m1) IL10 (Oc03396940_m1) 
IL6 (Oc04097053_m1) TGFB 1 (Oc04176122_u1) 
IL1-BETA (Oc03823250_s1) MRC1 (Oc06778204_m1) 
Biochemical Components 
Elastin (Oc06720017_g1) MMP2 (Oc03397553_m1) 
 MMP9 (Oc03397520_m1) 
 Biochemical Components (MMP Activity) 
7.2.22.1 Protein Extractions 
All tissue samples were homogenized in a High Salt Buffer (pH 7.5, 50 mM Tris base, 150 
mM NaCl, 5 M CaCl2, 1% Triton-X-100, 0.01 % Halt protease inhibitor cocktail, Pierce 
Biotechnology, Rockford, IL). Protein concentrations were quantified using the BCA Protein 
Assay Kit (Pierce Biotechnology, Rockford, IL) following the manufacturer’s instructions.  
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7.2.22.2 MMP Activity Assay 
MMP assay was adapted from the EnzChek Gelatinase/Collagenase protocol (Molecular 
Probes, Inc., Eugene, OR). 10 µg of protein for each sample was used. Samples were incubated 
with 1X Reaction buffer (diluted from 10X 0.5M Tris-HCl, 1.5 M NaCl, 50 mM CaCl2, 2 mM 
sodium azide, pH 7.6) followed by addition of DQ gelatin from porcine skin (100 µg/mL) at room 
temperature. The fluorescence intensity was read at an excitation of 495 nm and an emission at 
515 nm after 1 hour of incubation and 16 hours of incubation.  MMP values are calculated using 
Type IV collagenase/gelatinase standards where one unit of gelatinase A is defined as the amount 
that can hydrolyze 1 mg of type IV collagen within one hour at 37C, pH 7.5. The 16-hour 
incubation time point was optimized for use due to the increased sensitivity in measurements.  
 Ball Burst Mechanical Testing 
Vaginal mesh samples preserved in saline were used for ball burst testing to determine 
structural properties of the vaginal tissue post-implantation. Polypropylene mesh (n = 5) was tested 
alone to allow for comparison of mesh properties and for later calculations on determining tissue 
contributions. Mesh was placed between two metal clamps that is screwed into the apparatus setup 
on an Instron TM 4502 (Instron, Norwood, MA). At the top is a stainless-steel ball rod designed 
to push through a hole in the clamps. This ball is attached to a load cell, which is capable of up to 
5 kN of load.  
The ball rod was centered and lowered against each clamped sample at a constant rate of 
10 mm/min to a 0.5 N pre-load. Then, each sample was loaded to failure at a rate of 10 mm/min.  
The failure load (N) and elongation (mm) data are then utilized to create load-elongation 
curves to determine the structural properties. Stiffness (N/mm) was calculated as the maximum 
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slope of the over 20% of the failure elongation. Energy absorbed was calculated as the area 
underneath the curve until failure. 
 Statistical Analysis 
Based on previous studies, a sample size of 5 animals were deemed sufficient for 
determining statistical differences between groups in the analysis [73]. Descriptive statistical 
analysis was done to determine normality using Kolmogorov-Smirnov and Shapiro-Wilk tests with 
alpha = 0.05. Immunolabeling data for each anatomical location at both acute and chronic time 
points were assessed using one-way analysis of variance with Tukey post hoc test with p<0.05 
used to determine significance. Independent samples t-tests were used to determine differences 
based solely on anatomical location. In the case of data found to be not normally distributed, the 
comparison of non-parametric data was completed using a Kruskal-Wallis comparison with a 
Mann-Whitney post hoc. 
7.3 Results & Discussion 
 In Vitro Characterization of Scale-Up Rabbit IL-4 Coating 
A scale-up of the layer-by-layer coating onto a larger piece of mesh was developed for a 
relevant larger animal model of implantation. The protocol was modified to adapt to a 3x12 cm2 
piece of mesh and characterized for uniformity and bioactive functionality. Additionally, rabbit 
cytokines were incorporated to remain relevant to the change in animal model that was being 
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utilized. All of these factors combined allowed for testing the scale-up of the coating to a clinically 
relevant standard. All mesh pieces (large – 3x12 cm2 and small – 1x1 cm2) were irradiated via an 
adapted radio frequency glow discharge method described earlier [91, 92]. Preliminary work has 
confirmed the presence of a stable negative charge formed by the carboxylic acid groups on the 











The irradiated mesh was then coated with a series of polycationic and polyanionic polymer 
solutions utilizing the method of layer-by-layer deposition. These layers differ from physical 
adsorption in that they attach through the electrostatic interactions of oppositely charged layers. 
Chitosan was used as the polycation layers due to its nontoxic properties. It is known to be 
antibacterial, anti-tumoral, and has previously shown in vivo to encourage skeletal muscle tissue 
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growth [57, 93]. Additionally, several researchers have shown that alternatively activated 
macrophages produce chitinase and other chitinase-like molecules confirming a direct role in 
degrading chitin or chitin derivatives containing surfaces [94].  
For the polyanion layers, dermatan sulfate (also known as chondroitin sulfate B) is known 
for its role in regulating the extracellular matrix and its ability to enhance the bioactivity of IL-4 
in vivo [53]. Recombinant rabbit IL-4 was used to incorporate a controlled release mechanism in 
the polymer coating. The IL-4 cytokine has been shown in previous studies to shift the macrophage 
phenotype into the M2 pro-inflammatory state (35, 36). This has been associated with improved 
tissue remodeling outcomes (7, 8). The overall immunomodulatory strategy incorporates multiple 
components of a complex layered coating and cytokine release to mediate the macrophage 
response to mesh.  
In order to visualize the polymer components of the coating, a quality control using a stain 
of Alcian Blue was used for each batch of mesh manufactured. This allowed for confirmation of 
the properties of the coating on the macroscale and detection of uniformity of the coating. Figure 
38 depicts pristine mesh and coated mesh stained with Alcian blue. A magnified image of the mesh 
fibers closely shows the uniformity of the coating even throughout the mesh knots. Conversely, 
the lack of blue staining indicates that there is no presence of coating on the pristine mesh, serving 




Figure 38: Top Panel: Pristine Mesh stained with Alcian Blue. Bottom Panel: Increasing Magnifications of 
Coated Mesh stained with Alcian Blue. Black arrow indicates the blue dyed fibers that are characteristic to 
commercially available Gynemesh and not a part of 
 
 Cytokine Functional Assays  
Controlled release studies were conducted to determine the release profile of the rabbit IL-
4. Obtaining the release profile curve help determined an estimated dosage of IL-4 that would be 
released once the coating broke down.  Quality control for scaling up the larger pieces of mesh 
was done via sampling 1x1 cm2 pieces at multiple different locations to determine uniformity of 
IL-4 being released. The amount of IL-4 released was determined using ELISA assays. Release 
showed that the amount of IL-4 released in the first week was consistent with a burst release 
response with approximately 80% of the IL-4 being released. Interestingly, the plateau was 
consistent up until a non-detectable range of IL-4 was released by approximately 1 month. This 
aligns with previous kinetics of the coating determined by having 50 bilayers, confirming the 
ability to control the amount of release over time [50]. Additionally, this information confirms the 
desired release profile of releasing IL-4 in the early stages post-implantation. This early period of 
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modulation has the potential to allow for improved downstream outcomes as noted by previous 









 Macrophage Cultures  
Macrophages isolated from the bone marrow had higher cell viability (> 97%) and success 
during culturing periods than macrophages isolated from peripheral blood. A limiting factor with 
peripheral blood isolated macrophages was the increased contamination of red blood cells, which 
may have been alleviated with the use of a red blood cell lysis buffer. Thus, assessment of 























































macrophage functionality was completed using macrophages isolated from the bone marrow 
methodology.  
Due to the use of rabbit granulocyte-macrophage colony-stimulating factor (GM-CSF), the 
cells cultured were semi-adhesive in nature and therefore it was important to not complete full 
media changes during cultures. This allowed for a sustained release of macrophage secretions into 
the media and characterization of these secretions permitted further information about rabbit 
macrophages.  
7.3.3.1 Immunolabeling with RAM11 
In order to initially confirm the culture of macrophages, the cells were fixed and 
immunolabeled with a pan-macrophage marker, RAM11. This was the first step to confirming the 
presence of macrophages after isolations from bone marrow. Positively labeled RAM11 cells are 
shown in TRITC (Red) and counts indicate no significant differences in the number of 
macrophages cultured for each polarization group. However, it is important to note that 
approximately 40 – 60 % of the cultured cells were labeled as RAM11+ cells, translating to a 40 
– 60% efficiency when isolating from bone marrow. This remaining percentage may correlate to 
the culture of dendritic cells, red blood cells, and other cell debris coming from the bone marrow. 
Regardless, RAM11+ cells still indicate the presence of macrophages and further work to 






Figure 40:  Top Panel: Representative brightfield images of bone marrow-derived macrophages Bottom 

































































7.3.3.2 Assessment of Macrophage Polarization 
A large component of determining the macrophage phenotypic profile involved utilizing 
functional assays that are characteristic of macrophages. Specifically, the competing arginine 
pathways allows for the determination of what can be considered an M1 pro-inflammatory 
macrophage and what can be considered an M2 anti-inflammatory macrophage. It is widely known 
that M1 macrophages express the enzyme, nitric oxide synthase, that follows the pathway of 
metabolizing arginine into nitric oxide and citrulline. Alternatively, M2 macrophages are typically 
branded by the expression of the enzyme, arginase, that follows the pathway of hydrolysis of 
arginine into urea and ornithine.  
The nitric oxide Griess reagent system assay measured the production of nitric oxide in all 
groups of macrophage cultures. The assays showed that cells polarized with the pro-inflammatory 
cytokines (IFN- γ and LPS) significantly produced the highest amount of nitrite concentration 
(22.01 ± 3.53 µM) as compared to the other groups (M0 vs. M1, p = 0.0011 and M1 vs. M2, p = 
0.0002). This confirms the ability of rabbit macrophages isolated from the bone marrow to be 
capable of polarizing to the pro-inflammatory phenotype. Interestingly, the control M0 group also 
produced (7.39 ± 2.57 µM) nitrite concentrations and the M2 group produced very little (2.31 ± 
0.98 µM). This further confirms the concept of macrophages existing on a spectrum and exhibiting 






Figure 41: Functional assays to characterize in vitro macrophage polarization. Arginase and Nitric Oxide 




An arginase activity assay was used to measure the urea production in all groups of 
macrophage cultures. Arginase activity was measured as the µg of urea per µL of lysate. Results 
from the assays showed that macrophages polarized with rabbit IL-4 expressed a significant 
increase in urea concentration in the lysates as compared to the other treatment groups (14.25 ± 
1.81 µg Urea per µL lysate, p = 0.0002).  
A panel of pro-inflammatory and anti-inflammatory markers were used to determine the relative 
gene expression in further assessing the phenotypic profile of the macrophages cultured with either 
the M1-inducing cues (LPS and IFN- γ) or M2 cues (IL-4).  All A260/A280 ratios were found above 
or at 2.0, which confirms purity and well-solubilization of RNA. M1 polarized macrophages 
expressed increased levels of pro-inflammatory markers (IFN-γ, IL-6, and IL-1β) as compared to 




































expression in the levels of anti-inflammatory markers (Arg1, IL-10, TGF- β, and Mrc1) in the M2 
polarized macrophages as compared to the control (M0) and M1 polarized macrophages (Figure 
42, bottom panel). The increased expression in each respective pro-inflammatory and anti-
inflammatory marker further confirms the representative traits on the polarization spectrum for 
macrophage phenotypes.   
 
Figure 42: Relative Gene Expression of Pro-inflammatory and Anti-inflammatory markers. Data is 
normalized to M0 control and represented from 3 biological replicates and (n = 3) technical replicates. Values 




































 Cytokine Bioactivity Assays 
A set of in vitro assays were completed to characterize the effect of mesh on macrophages 
as well as the bioactivity of the IL-4 loaded onto the coated mesh. Three different groups (Pristine, 
Polymer-only, IL-4 coated) of mesh were incubated with macrophages. The macrophages were 
immunolabeled with RAM11, assessed for nitric oxide production, arginase activity, and gene 
expression for pro-inflammatory/anti-inflammatory markers. At the end of cultures, both coated 
mesh groups did not inhibit the ability for macrophages to grow. However, there was an overall 
decrease in the number of RAM11+ cells observed in the cultures with mesh as opposed to the 
cultures treated with cytokines.   
The nitric oxide Griess reagent system assay measured the production of nitric oxide in all 
groups of macrophage cultures. The assays showed that cells exposed to the pristine mesh group 
produced a significantly high amount of nitrite concentration compared to the other groups (M0, 
p < 0.0001; IL-4 Coated Mesh, p < 0.001; Polymer only coated mesh, p < 0.001) (Figure 45). This 
indicates that the cells activated towards the M1 pro-inflammatory phenotype when cultured with 
pristine mesh. However, when cells were cultured with IL-4 coated mesh or the polymer-only 
coated mesh, there was significantly less nitrite production when compared between mesh group 
and the M1 polarized (IFN- γ and LPS) group. These findings indicate that the IL-4 mesh and the 
polymer-coated mesh are capable of preventing the activation of a pro-inflammatory M1 response 
during in vitro cultures.  
An arginase activity assay was used to measure the urea production in all groups of 
macrophage cultures. Arginase activity was measured as the µg of urea per µL of lysate. Results 
from the assays showed that macrophages cultured with the IL-4 coated mesh and the polymer-
only coated mesh expressed an increase in urea concentration when compared to the pristine mesh 
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groups and the other cell culture groups M0 and M1 (Figure 45). While the activity was not as 
high as M2 polarized (IL-4) macrophages, this still indicates the possibility of both the IL-4 coated 
mesh and the polymer-only coated mesh to activate the anti-inflammatory M2 phenotype during 
in vitro cultures.  
A panel of pro-inflammatory and anti-inflammatory markers were used to determine the 
relative gene expression in further assessing the phenotypic profile of the macrophages cultured 
with all mesh groups (Pristine mesh, IL-4 Coated mesh, Polymer-only Coated mesh).  All 
A260/A280 ratios were found above or at 2.0, which confirms purity and well-solubilization of 
RNA. The pristine mesh and polymer-only coated mesh expressed an overall increase in the pro-
inflammatory markers (iNOS, IFN-γ, IL-6, and IL-1β) when compared with the IL-4 coated mesh.  
Upon observing the expression of the anti-inflammatory markers (Arg1, IL-10, TGF- β, and Mrc1), 
the IL-4 coated mesh showed an increase in expression when compared to the pristine mesh 
cultures. Interestingly, in the case of IL-10 and Mrc1 expression, the polymer-only coated mesh 
cultures were found to have expressed even higher in these markers than the IL-4 coated mesh or 
the pristine mesh. This indicates that the coating itself may have anti-inflammatory effects, as seen 




Figure 43: RAM11+ cells shown in red for all groups. Nuclei are stained with DAPI shown in blue. Scale bar 
is 1000 µm. 
 
M0 M1 (LPS & IFN- γ) M2 (IL-4) 
Pristine Mesh Polymer-only Coated Mesh IL-4 Coated Mesh 
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Figure 44: Magnified images of each treatment group. RAM11+ cells are shown in red, nuclei are shown in 
blue. 
Pristine Mesh Polymer-only Coated Mesh IL-4 Coated Mesh 





































































































Figure 45: Functional assays with the mesh cultures. Left graph depicts nitric oxide production between 















































































































Figure 46: Relative Gene Expression of Pro-inflammatory markers from bioactivity assays. Data is 
normalized to M0 controls and represented from 3 biological replicates and (n = 3) technical replicates. 





































































































Figure 47: Relative Gene Expression of Anti-inflammatory markers from bioactivity assays. Data is 
normalized to M0 controls and represented from 3 biological replicates and (n = 3) technical replicates. 
Values are shown as Mean Fold Change ± SEM 
 Surgical Outcomes and Gross Morphologic Findings 
All animals implanted with IL-4 coated mesh were closely monitored and survived until 
their respective time points.  At the time of necropsy, all rabbits were carefully observed for the 
presence of adhesions and characteristics were noted according to the Mazuji classification (Table 
6) of rating peritoneal adhesions [95, 96]. At both 14 and 90 days, there was noticeable scar tissue 
surrounding the subcutaneous implant location that is characteristic of a normal response to a 
material. Intra-abdominally, there were adhesions between the omentum and the internal organs, 
indicative of an active response to the mesh and the surgery itself. Adhesions are defined as fibrous 
scar tissue that connect formerly unconnected serosal exteriors of intraabdominal organs either to 
































































































in the peritoneal cavity can be described as Grade 2, as in very easily separable with limited 
attachment at all between internal organs (Figure 48). During isolation of the vaginal implant, there 
was some limited attachment of bowels to the implant that was easily detached through blunt 
dissection. Additionally, there was no presence of any vascularized adhesion development, 
indicative of a severe response.  At 90 days post-implantation, there was a very limited presence 
of adhesions in the peritoneal cavity when compared to the peritoneal space of a rabbit implanted 
with pristine mesh (Figure 49). The level of adhesions observed can be categorized as existing 
both in Grade 1 and Grade 2. Similar to the 14-day implants, it was possible to separate the 
adhesions that were present through simple blunt dissection, though was rarely needed. This can 
also be evidenced by the lack of connective tissue surrounding the vaginal implants (Figure 53) 
where it was easier to isolate compared to pristine mesh implants. Based on these findings, the 90-
day IL-4 mesh implants were found to have the most reduced rate of peritoneal adhesion as noted 












Table 7: Adhesion grading according to Mazuji classification [95, 96] 
Grade Description of Grade 
0 No adhesion 
1 Very small, irregular adhesion 
2 Easily separable medium intensity adhesion 
3 Intense, not easily separable regular adhesion 
4 Very intense, not easily separable, homogenous adhesion 
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Figure 48: Representative images from 14 days post-implantation of pristine mesh (Left) and IL-4 coated 
mesh (both Right) indicating levels of adhesions observed at time of necropsy in the peritoneal space. 
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Figure 49: Representative images from 90 days post-implantation of pristine mesh  (Left) and IL-4 coated 
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Figure 51: Vaginal mesh-tissue explants at 14 days post-implantation for pristine mesh and IL-4 coated mesh 
 




















Figure 53: Vaginal mesh-tissue explants 90 days post-implantation for pristine mesh and IL-4 coated mesh 














 Histological Analysis Tissue Morphology 
Histological analysis using hematoxylin and eosin staining was performed to observe the 
basic tissue morphology and overall architecture along with cellular characteristics and infiltration 
near the implants. All implants revealed a mononuclear cell population surrounding mesh fibers 
followed by the presence of a few foreign body giant cells. Total cellular response at 14 days post-
implantation of IL-4 coated mesh implants in the vagina was increased by 21.5 % than cellular 
response of IL-4 coated mesh implants subcutaneously (p = 0.0005). Additionally, the 
subcutaneous IL-4 coated mesh implants had significantly higher cellularity at 14 days post-
implantation compared to 90 days (42.4 % decrease at 90 days, p < 0.0001). Vaginal IL-4 coated 
mesh implants followed a similar trend with a 58.4 % decrease in cellularity surrounding mesh 
fibers at 90 days when compared to cellularity at 14 days post-implantation (p < 0.0001). There 
were no differences observed at 14 days post-implantation in cellularity for subcutaneous implants. 
However, at 14 days post-implantation, the vaginal IL-4 coated mesh implants were 32.6 % 
significantly higher in the total cellular response than vaginal pristine mesh implants (p = 0.0273). 
Interestingly, there were no significant differences in the total cell response to mesh fibers at 90 
days regardless of the type of mesh or the anatomical location of implantation.  
All mesh fibers were surrounded with an increased cluster of mononuclear cells, 
representative of a response to the implant itself. There were many distinct differences noted 
between the pristine mesh implants and the IL-4 coated mesh implants at both anatomical 
locations, with the most striking being the presence of organized connective tissue surrounding the 
IL-4 coated mesh fibers at both 14- and 90-days post-implantation. This is in addition to variations 
in the connective tissue architecture surrounding the implants as well. As noted in Figure 54, a 
distinct direction of the fibrous tissue can be characterized in both subcutaneous and vaginal IL-4 
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mesh implants whereas the pristine mesh implants mostly have disorganized connective tissue. 
However, it is important to note that not all mesh fibers in the IL-4 mesh implants displayed a 
straight alignment, but instead the appearance of denser connective tissue overall was observed as 
compared to the looser connective tissue observed in pristine mesh implants.  
The dense connective tissue response can be further described as either regular or irregular, 
based on the orientation of fibers. The distinct alignment of the fibers in a single direction noted 
in Figure 54 is defined as regular connective tissue, as seen in other tissue types like tendons, etc 
[97]. This is commonly associated with increased tensile strength in that direction. However, in 
the case of irregular connective tissue, the fibers are arranged randomly in all directions. 
Interestingly, the fibers surrounding the IL-4 coated mesh implants remain dense and follow the 
fiber circumferentially, suggesting an integration into the tissue. The connective tissue fibers 
surrounding the pristine mesh implants are loose and do not follow a distinct pattern, and thus can 
suggest irregularity, such as what is observed in the skin.  
Another important observation was the presence of blood vessels in a wider field of view 
when imaging mesh fibers. The vascularity surrounding mesh implants will be discussed in a later 
section, but histologically, there was a notable presence of blood vessels that appeared equidistant 
from the fibers all around (Figure 54 Subcutaneous IL-4 Coated Mesh implant black arrows). 
These were only qualitatively observed in the IL-4 mesh implants at 14- and 90-days post-
implantation and not in the pristine mesh implants.  
There was also the presence of eosinophils observed similarly to the pristine mesh 
implants, but noticeably a farther distance away from the mesh fibers. However, these were mostly 
observed at 14 days post-implantation. Additionally, after 14 days, in a few fibers, it was possible 
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to still see remnants of the coating (Figure 58, black arrows). This is especially interesting because 
it indicates that the in vitro assays are difficult to correlate directly to in vivo profiles.   
 
Figure 54: Representative histological hematoxylin and eosin images of pristine mesh and IL-4 coated mesh 
implants at 14 days post implantation. Black dashes indicate differences in aligned connective tissue observed 
that was not present in pristine mesh implants 
 



































Figure 55: Representative H&E images of Pristine Mesh and IL-4 Coated Mesh subcutaneous implants at 14- 
and 90-days post-implantation. All scale bars are 50 µm. 
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Figure 56: Representative H&E images of Pristine Mesh and IL-4 Coated Mesh vaginal implants at 14- and 




Figure 57: Quantified cellular response of host response to pristine mesh and iL-4 coated mesh. Data shown 




Figure 58: IL-4 coated mesh fibers with remnants of the coating present after 14 days of implantation. 
Indicated by the black arrows. All scale bars are 50 µm 
 
 
 Collagen Quantitative Analysis 
Masson’s trichrome staining revealed the presence of a collagen capsule surrounding all 
mesh fibers in both subcutaneous and vaginal IL-4 coated mesh implants. The subcutaneous IL-4 
coated mesh implants showed a 14.6 % increase in the % collagen area surrounding mesh fibers 
from 14 days to 90 days post-implantation (p = 0.0263, Figure 60). Additionally, there were 
significant differences in collagen formation at 14 days between the subcutaneous and vaginal 
implants with vaginal implants showing on average 15.5 % more collagen area surrounding mesh 
fibers than the subcutaneous implants (p = 0.0241, Figure 60). Interestingly, there were no 
significant differences found in % collagen area surrounding IL-4 coated mesh fibers in vaginal 
implants between 14- and 90-days post-implantation. However, upon comparison to the pristine 








at 14 days in the IL-4 coated mesh (subcutaneous, p = 0.0001; vaginal, p = 0.0001, Figure 60). The 
same trend was observed for subcutaneous implants at 90 days post-implantation, where the IL-4 
coated mesh implants were found to have significantly higher % collagen than the pristine mesh 
implants (p < 0.0001). However, there were no significant differences determined at 90 days 
between the pristine mesh and the IL-4 coated mesh for the vaginal implants.  
An interesting observation in the IL-4 coated mesh implants was the presence of dense 
collagen fibers surrounding individual mesh fibers (Figure 59). As mentioned previously, this 
characteristic is unique to the IL-4 coated mesh implants and observed with a distinct aligned tissue 
in one direction. In some cases, the collagen fibers had densely formed circumferentially around 
the mesh fibers, almost as though everything was being incorporated into the tissue. Other research 
involving the implantation of extracellular matrix scaffolds have shown similar findings consistent 
with a constructive remodeling response, specifically with an increase in the pro-regenerative 




Figure 59: Representative images of Masson’s Trichrome for subcutaneous and vaginal mesh-tissue implants 















Figure 60: % Area Collagen Quantification of Masson’s Trichrome staining using ImageJ algorithm. Data 
shown as mean ± SEM. 
 
 



















































 Angiogenesis Analysis 
At both 14- and 90-days post-implantation, all IL-4 coated mesh implants showed the 
presence of blood vessels surrounding individual mesh fibers (Figure 61).  In order to label 
endothelial cells lining blood vessels, especially those that are newly formed, a CD31 marker was 
used via immunohistochemistry techniques. Interestingly, there were no significant differences 
observed between groups of the IL-4 coated mesh implants at either 14 day or 90 days of 
implantation or based on anatomical location, either subcutaneous or vaginal. However, compared 
to the pristine mesh group, both subcutaneous and vaginal IL-4 coated mesh implants had 
significantly higher CD31+ blood vessel density found at both 14 days and 90 days (subcutaneous 
14 days ( p = 0.0068); vaginal 14 days (p < 0.0001), subcutaneous 90 days (p = 0.0167); vaginal 
90 days (p = 0.0128)). This indicates a trend that the IL-4 coated mesh induced an increase in 
blood vessel density surrounding individual mesh fibers. This was confirmed through histological 
examination as mentioned in earlier sections (Figure 54).  
A unique observation at 90 days was the presence of blood vessels directly outside the 
perimeter of individual mesh fibers of both subcutaneous and vaginal IL-4 coated mesh implants 
as noted in Figure 63. This indicates an enhanced vascular permeability shown in the response to 
the IL-4 coated mesh implants. Additionally, by visual qualitative observation, it was possible to 
notice an increase in the presence of blood vessels surrounding individual mesh fibers as noted in 




Figure 61: anti-CD31 immunolabeling of subcutaneous and vaginal IL-4 coated mesh implants 14- and 90-















Figure 62: Quantitative analysis of CD31+ blood vessels in mesh implants. Data shown as mean ± SEM. 
 
 




















Figure 63: Notably increased blood vessels surrounding IL-4 coated mesh fibers in both subcutaneous and 
vaginal implants at 90 days post-implantation. All scale bars are 50 µm. 
 
 
Figure 64: Notably increased presence of blood vessels surrounding individual IL-4 coated mesh fibers in 
another field of view with Masson’s trichrome staining in both subcutaneous and vaginal implants at 90 days 














 Macrophage Analysis 
All IL-4 coated mesh implants elicited an immune response at 14 days which remained 
present at 90 days post-implantation (Figure 65). A pan-macrophage marker, RAM11, was utilized 
to immunolabel the presence of macrophages surrounding individual mesh fibers. In the case of 
both subcutaneous and vaginal IL-4 coated mesh implants, there was a significant decrease in the 
number of macrophages (subcutaneous 35.2 % decrease, p = 0.0033; vaginal 44.8 % decrease, p = 
0.0003) from 14 days to 90 days post-implantation (Figure 66). Upon comparing to the pristine 
mesh group, the IL-4 coated mesh had significantly higher macrophage number at 14 days in the 
subcutaneous implantation (p < 0.0001). However, there were no significant differences between 
the pristine mesh and IL-4 coated mesh in the vaginal implantation at 14 days. Interestingly, 
comparing vaginal implantation site at 90 days, there were significantly less macrophages in the 
IL-4 coated mesh implants than the pristine mesh implants (p = 0.0036). There were no significant 
differences observed in the subcutaneous implantation site when comparing between pristine mesh 






Figure 65: anti-RAM11 immunolabeling of subcutaneous and vaginal IL-4 coated mesh implants at 14- and 















Figure 66: RAM11+ immunolabeling of macrophages surrounding individual mesh fibers both subcutaneous 






 Elastin Qualitative Analysis 
 
Figure 67: A, B, D, E. Elastic fibers in IL-4 coated mesh vaginal implants at 14 days post-implantation. C & 
F. Elastic fibers in IL-4 coated mesh vaginal implants at 90 days post-implantation. 
 
 
Similar to the pristine mesh implants, a noticeable difference in the elastic fiber presence 
was observed at 14 days in the IL-4 coated mesh implants (Figure 67). Fragmented fibers were 
observed throughout the vaginal tissue and in particular near the mesh fibers, a fragmented singular 
elastic response was detected. Additionally, at 90 days post-implantation, similarly fragmented 
elastic fibers can be seen (Figure 67C). However, it was possible to observe elastic fibers in the 
vicinity of a mesh fiber, which was not possible with earlier pristine mesh implants (Figure 67F). 
Nevertheless, these fragmented elastic fibers are still indicative of a maladaptive tissue response.  
A B C 
D E F 
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 Gene Expression Analysis 
In order to further understand the inflammatory response in the tissue explants, TaqMan 
gene expression assays were performed using a series of pro-inflammatory and anti-inflammatory 
markers. All A260/A280 ratios were found above or at 2.0, which confirms purity and well-
solubilization of RNA extracted. The subcutaneous implants were normalized to abdominal 
muscle control tissue and vaginal implants were normalized to vaginal control tissue. At 14 days, 
subcutaneous pristine mesh implants showed increased expression in all pro-inflammatory 
markers, but significantly increased expression in IFN-γ and IL-1β when compared to abdominal 
muscle control (IFN-γ, p = 0.0014; IL-1β, p = 0.0008) and IL-4 coated mesh (IFN-γ, p = 0.0011, 
IL-1β, p = 0.0003) (Figure 68). However, IL-4 coated mesh implants were significantly 
upregulated in IL-6 expression when compared to abdominal muscle controls (p = 0.0161). There 
were no significant differences observed in iNOS expression, however both mesh implants did 
show a trend of increased expression.  
At 14 days, the subcutaneous IL-4 coated mesh implants were associated with a significant 
increase in the anti-inflammatory markers (TGF-β, IL-10, and Mrc1) when compared to pristine 
mesh implants (TGF- β, p = 0.0003; IL-10, p = 0.0030; Mrc1, p = 0.0348) (Figure 69). There were 
no significant differences observed in the Arg1 expression between mesh groups. This indicates 
that the IL-4 eluted from the coating does have a direct impact on the inflammatory profile of the 
surrounding tissue. Similarly, at 14 days, the vaginal pristine mesh implants were significantly 
upregulated in the pro-inflammatory markers, IFN-γ and IL-1β when compared to the vaginal 
control (IFN-γ, p = 0.0037; IL-1β, p = 0.0050) and the IL-4 coated mesh implants (IFN-γ, p = 
0.0081; IL-1β, p = 0.0012) (Figure 70). Similar to the abdominal implants, the IL-4 coated mesh 
implants were significantly upregulated in IL-6 expression when compared to the vaginal controls 
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(p = 0.0129). There were no significant differences observed for iNOS expression, however the 
values did trend towards an increase in expression in the mesh implants. The vaginal IL-4 coated 
mesh implants were significantly upregulated in Arg1 and TGF-β expression at 14 days (Arg1, p 
= 0.0316; TGF-β, p = 0.0167) (Figure 71). There were no significant differences observed in 
expression of IL-10 and Mrc1 between groups. 
 
 
Figure 68: Rabbit Subcutaneous Pro-inflammatory profile at 14 days post-implantation. Samples are 
normalized to abdominal muscle control. Data is shown as (n = 3 – 5) biological replicates with (n = 3) 













































Figure 69: Rabbit Subcutaneous Anti-inflammatory profile at 14 days post-implantation. Samples are 
normalized to abdominal muscle control. Data is shown as (n = 3 – 5) biological replicates with (n = 3) 
technical replicates. Values are represented as mean fold change ± SEM 
 
 
Figure 70: Rabbit Vaginal Pro-inflammatory profile at 14 days post-implantation. Samples are normalized to 
Vaginal control. Data is shown as (n = 3 – 5) biological replicates with (n = 3) technical replicates. Values are 




















































































Figure 71: Rabbit Vaginal Anti-inflammatory profile at 14 days post-implantation. Samples are normalized 
to Vaginal control. Data is shown as (n = 3 – 5) biological replicates with (n = 3) technical replicates. Values 
are represented as mean fold change ± SEM 
 
At 90 days, the subcutaneous pristine mesh implants expressed a significant increase in 
iNOS and IL-1β expression when compared to abdominal muscle control (iNOS, p = 0.0006; IL-
1β, p = 0.0268), and pristine mesh implants (iNOS, p = 0.0004; IL-1β, p = 0.0215) (Figure 72). 
There were no significant differences observed in regulation of IFN-γ and IL-6 between groups. 
Interestingly, while there seemed to be a trend of increasing expression in the IL-4 coated mesh 
groups for the anti-inflammatory panel of markers, there were no significant differences found 
between groups in expression of Arg1, TGF-β, IL-10, and Mrc1 at 90 days for subcutaneous 
implants (Figure 73).  
Pristine mesh vaginal implants showcased a significantly increased expression in all of the 
pro-inflammatory markers (iNOS, IFN-γ, IL-1β, and IL-6) when compared to vaginal controls 
(iNOS, p = 0.0336; IFN-γ, p = 0.0008; IL-1β, p = 0.0067; IL-6, p = 0.0180) (Figure 74). Pristine 
mesh vaginal implants also showed significantly increased expression when compared to IL-4 














































































days, the IL-4 coated mesh vaginal implants showcased a significant increase in the anti-
inflammatory markers, Arg1 (p = 0.0439) and Mrc1 (p = 0.0381) when compared to pristine mesh 
implants indicating a possible mediating effect with the eluted IL-4 (Figure 75). There were no 
significant differences in the regulation of TGF-β and IL-10, thought the IL-4 coated mesh 
implants did show a trend of increased expression.  
 
 
Figure 72: Rabbit Subcutaneous Pro-inflammatory profile at 90 days post-implantation. Samples are 
normalized to Abdominal Muscle control. Data is shown as (n = 3 – 5) biological replicates with (n = 3) 




















































































Figure 73: Rabbit Subcutaneous Anti-inflammatory profile at 90 days post-implantation. Samples are 
normalized to abdominal muscle control. Data is shown as (n = 3 – 5) biological replicates with (n = 3) 
technical replicates. Values are represented as mean fold change ± SEM 
 
 
Figure 74: Rabbit Vaginal Pro-inflammatory profile at 90 days post-implantation. Samples are normalized to 
Vaginal control. Data is shown as (n = 3 – 5) biological replicates with (n = 3) technical replicates. Values are 





































































































































































Figure 75: Rabbit Vaginal Anti-inflammatory profile at 90 days post-implantation. Samples are normalized 
to Vaginal control. Data is shown as (n = 3 – 5) biological replicates with (n = 3) technical replicates. Values 

















































































Figure 76: Rabbit vaginal matrix metalloproteinases and elastin expression at both 14- and 90-days post-
implantation. Samples are normalized to vaginal control. Data shown as (n = 3 – 5) biological replicates with 
(n = 3) technical replicates. Values are represented as mean fold change ± SEM 
 
Pristine mesh implants all expressed significantly higher MMP2 and MMP9 when 
compared to vaginal controls (MMP2, p = 0.0039; MMP9, p = 0.0039) and IL-4 coated mesh 





















































However, pristine mesh implants also significantly expressed higher elastin when compared to 
vaginal controls (p = 0.0016) and IL-4 coated mesh (p = 0.0006). On the other hand, IL-4 coated 
mesh implants had markedly decreased expression in MMP9 and elastin at 14 days but an increase 
when compared to vaginal controls.  
At 90 days, both the pristine mesh implants and IL-4 coated mesh implants showed 
increased MMP2, MMP9 and elastin expression when compared to vaginal controls. However, 
MMP9 expression was significantly increased when comparing to vaginal controls for pristine 
mesh (p = 0.0053) and for IL-4 coated mesh (p = 0.0231). In terms of elastin expression, pristine 
mesh implants had significantly higher expression (p = 0.0048) when compared to vaginal controls 
and (p = 0.0114) the IL-4 coated implants. This provides further insight into the histological 
findings of the maladaptive response regarding elastic fibers observed earlier. The increase in 
MMP2 and MMP9 expression can be associated with increased tissue degradation and changes in 
matrix remodeling.  
 Gelatinase Assay 
In order to assess the matrix-metalloproteinase levels in the IL-4 coated mesh implants, a 
gelatinase substrate degradation assay was performed allowing for the measurement of gelatinase 
activity. There were no significant differences in gelatinase activity between the vaginal control 
and IL-4 coated mesh implanted vaginally after 14 days (Figure 77). However, there was a 
significant increase in activity at 90 days post-implantation of the IL-4 coated mesh (p = 0.0106) 
compared to the vaginal control, indicating MMP activity was upregulated during the chronic 
immune response (Figure 77). There was also a significant increase in activity at 90 days post-
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implantation of the IL-4 coated mesh (p = 0.0009) compared to the IL-4 coated mesh at 14 days. 
Interestingly, at 14 days post-implantation, there was a significant decrease in gelatinase activity 
in the IL-4 coated mesh implants when compared to pristine mesh implants (p = 0.0454). A similar 
trend was observed at 90 days post-implantation, where the IL-4 coated mesh implants showed 
significantly less activity than the pristine mesh implants, indicating that the IL-4 coated mesh was 




Figure 77: Gelatinase Activity comparing Vaginal Controls to 14- and 90-days post-implantation of pristine 
mesh and IL-4 coated mesh. Data shown as values ± SEM. 
 Ball Burst Mechanical Testing Outcomes 
In order to estimate individual vaginal tissue structural properties, ball-burst mechanical 
tests were performed on the IL-4 coated mesh-tissue complexes at both 14- and 90-days post-
























































in the estimated vaginal tissue contribution calculated at 14 days and 90 days post-implantation. 
However, upon comparison to pristine mesh implants, IL-4 mesh coated implants depicted a 
significantly higher estimated vaginal tissue contribution at both 14- and 90-days post-
implantation (p = 0.0452, p = 0.0059). The higher vaginal stiffness indicates that there was less 
loss in structural integrity overall with the IL-4 mesh implants.  
It is important to note that the polymer coated mesh was also mechanically tested for load 
and stiffness and no differences were observed in the mechanical integrity of the mesh when 





Figure 78: IL-4 Coated Mesh A. Load to Failure of mesh-tissue complex B. Stiffness of mesh-tissue complex 

















































































Figure 79: Representative Load-Extension curves for Gynemesh, Vaginal IL-4 Coated Mesh Implants at 14- 
and 90-days post-implantation 
 
 
Figure 80: Stiffness of the Mesh-Tissue Complex for Pristine Mesh and IL-4 Coated Mesh at both 14- and 90-
days post-implantation. Data shown as values ± SD. 


























































Figure 81: Load at Failure for Mesh-Tissue Complex for Pristine mesh and IL-4 Coated mesh at both 14- and 



































Figure 82: Estimated Vaginal Tissue Contribution for Pristine mesh and IL-4 Coated mesh at both 14- and 
90-days post-implantation. Data shown as values ± SD. 
7.4 Conclusions 
Overall, the findings from the second aim can be split into two main categorical divisions. 
The first portion of the study was aimed at scaling up and validating the bioactive rabbit IL-4 
release from a polymer coating. This principally involved utilizing in vitro assays and rabbit 
cytokines to understand the inflammatory spectrum. We were able to specifically observe the 
functionality of rabbit macrophages cultured in vitro and further characterize the pro-inflammatory 
and anti-inflammatory expression. We were able to incorporate recombinant rabbit IL-4 into a 
layer-by-layer coating followed determining a distinct release profile, consisting of 80% of IL-4 
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released in the first week. This follows our desired profile since IL-4 released in this acute phase 
is necessary to be impactful on macrophage polarization capabilities. This was in addition to 
macrophage polarization cultures confirmed through functional assays and gene expression to 
indicate the pro-inflammatory and anti-inflammatory profiles. The bioactivity assays from these 
macrophage cultures further elucidated the IL-4 being released was capable of polarizing naïve 
macrophages towards an M2-like profile.  
Following this set of in vitro characterization, the second portion of this aim focused on in 
vivo implantation of the IL-4 coated mesh in a rabbit model of lumbar colpopexy. We found 
distinct host responses to IL-4 coated polypropylene mesh implanted both subcutaneously and 
vaginally with overall changes in tissue architecture indicating changes in remodeling that can be 
characterized through collagen deposition, vascularity, and a variety of immune expression 
markers. Upon further histological analysis, specifically observing collagen formation, the IL-4 
coated mesh implants did showcase higher percentages in the area of collagen when compared to 
their pristine mesh counterparts. While a collagen response is usually one associated with the 
typical pathway of inflammation and fibrotic tissue formation [1, 39, 40], the important idea is to 
also consider specific characteristics regarding the collagen that is surrounding the implant. For 
instance, with the IL-4 coated mesh, we observed these oriented dense collagen fibers indicative 
of an active remodeling response related to tissue integration downstream and a homogenous 
architecture. Additionally, we must take into consideration the higher percentage of native 
collagen present in the tissues, especially in the vagina.  
Evidence indicating that this increased collagen percentage does not necessarily correlate 
with the formation of scar tissue or a fibrotic capsule is the enhanced angiogenesis observed 
surrounding mesh fibers. In the case of scar development, it is possible to see dense collagen fibers, 
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but a lack of vascularity leading to the compacture component often seen surrounding implants or 
the wound site. Often, fibrotic reactions are harmful when considering the needs of the host and 
nutrient supply. However, in the case of the IL-4 coated mesh implants, we did detect heightened 
vascularity surrounding individual mesh fibers. This indicates that the surrounding tissue response 
not only consisted of an aligned homogenous connective tissue but also one that was adequately 
supplied in terms of vascularity. These are all factors to consider upon implant integration with 
tissue outcomes. Of course, with the observation of enhanced angiogenesis can also be a concern 
for mechanisms relying on tumor progression. However, it is also important to note that other 
indicators of tumor growth, such as changes in collagen where the connective tissue is 
progressively destroyed as seen in the cases of malignant cancer cells [39, 100, 101]. We did not 
detect any presence of lesions either.  
This aim also focused on understanding the immune response to the IL-4 coated mesh using 
strategies unique methods of identifying macrophage behavior. We were able to recognize 
macrophages surrounding mesh fibers using the pan-macrophage marker, RAM11. However, we 
were limited in the abilities to label the subtype of macrophage that was surrounding each mesh 
fiber. Nevertheless, there are many assumptions we can make about characterizing the phenotype 
based on all other evidence gathered (collagen deposition, angiogenesis, IL-4 promotion, gene 
expression, etc.). For instance, we know that the anti-inflammatory M2 macrophage phenotypic 
subtype produce high levels of arginase, TGF- β, IL-10 and Mrc1[44, 47, 48, 72, 94, 102]. 
Additionally, M2 macrophages have previously been known to promote angiogenesis and recruit 
cells in constructive tissue remodeling.  
Our methods of evaluating the immune response at a deeper level included using a marker 
for angiogenesis, anti-CD31, and characterizing gene expression in the implant-specific tissues at 
 140 
each time point using a set of known pro-inflammatory and anti-inflammatory markers. As 
mentioned earlier, we did see increased vascularity surrounding the IL-4 coated mesh fibers at 
both 14- and 90-days post-implantation when comparing to pristine mesh implants at those time 
points in both subcutaneous and vaginal implants. This indicates an overall increase in vascularity 
regardless of location that begins at the early stage of the immune response and remains during 
longer times of implantation.  
The panel of pro-inflammatory markers used to measure expression in the subsequent 
tissues consisted of characteristic indicators of macrophages that can be classified on the M1 
phenotypic end of the spectrum. Pristine mesh implants consistently had increased iNOS, IFN-γ, 
IL-1β, and IL-6 expression when compared to control tissues in both vaginal and subcutaneous 
implants at both 14- and 90-days post-implantation. Interestingly, we began to see changes in the 
pro-inflammatory expression of the IL-4 coated mesh implants when compared to both control 
tissues and the pristine mesh implants. While there was an overall increase in expression compared 
to control tissues, we did observe a general decrease in pro-inflammatory expression in the IL-4 
coated mesh implants compared to pristine mesh implants. These findings suggest that the IL-4 
coated mesh is capable of decreasing the pro-inflammatory expression in tissues at both 14 and 90 
days of implantation. Further indicators of this are derived with the anti-inflammatory panel of 
markers, Arg1, TGF-β, IL-10, and Mrc1, where pristine mesh implants in both subcutaneous and 
vaginal spaces and at both 14 and 90 days of implantation were decreased overall when compared 
to both control tissues and the IL-4 coated mesh. Interestingly, the overall finding of increased 
anti-inflammatory expression in the IL-4 coated mesh implants in all conditions further suggests 
the beneficiary effects of the coating being substantially present. While it was not possible to use 
surface markers to specifically label the subtype of macrophages, we have shown strong 
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indications for the population of macrophages that may have dominated in the host response to the 
IL-4 coated mesh as compared to the pristine mesh.  
Overall, by targeting the early immune response, we have shown changes in the tissue 
degradation responses with indications of better mesh-tissue integration and formation. This was 
associated with enhanced mechanical contributions from the tissue instead of the mesh, suggesting 
an improvement in implant integration. We did not see the presence of an aggravated scar 
formation nor any indications of tumoral factors, instead there was a reduction in the tissue 
adhesions and changes in the overall immune response. There is stronger evidence in the dynamic 
tissue remodeling process as these findings are able to capture trends that may have been observed 
on separate occasions, but not together in the same study.  
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8.0 Translational Impact 
The use of polypropylene mesh provides mechanical support to many requiring prolapse 
repair. However, the literature has shown over time, that with the implantation of mesh, also 
coincides the degradation of the surrounding tissues. Persistent inflammation has been linked to 
women experiencing complications with mesh.  
In an attempt to increase chances of success, robust studies from clinical trials assessing 
differences in the vaginal surgical procedures have found that introducing behavioral intervention 
such as pelvic floor muscle training did not improve urinary symptoms at 6 months or prolapse 
outcomes two years post-surgery[28, 103]. This suggests that there may be more complicated 
mechanisms leading to the symptoms experienced. As noted, there are so many biological and 
chemical changes with the implantation of mesh itself, it seems a complex solution would be 
necessary to address an overall improvement in mesh-tissue interactions.   
Restoring apical support is the most common surgical procedure, and yet there remains to 
be little known about the safety and efficacy. The complications experienced are still high in 
number and surgical models like the rabbit lumbar colpopexy allow for a cost-effective method to 
understanding different stages of mesh impacting the host response. Models such as these can 
provide further information for the reasoning behind success rates and complication rates that are 
seen in the clinic. 
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9.0 Limitations and Future Directions 
There were several limitations in this study that must be noted. Most significantly upon 
assessing the inflammatory response, the lack of rabbit M1 and M2 specific antibodies. While it 
was possible to label cells with a validated pan-macrophage marker, the limitation in the rabbit 
model for getting into the specificity of the macrophage spectrum led to focusing on other aspects 
of the host immune response. However, attempts to mitigate this were completed by utilizing other 
methods of evidence for characterizing the macrophage profile such as the use of gene expression 
and functional assays. 
 However, there still remains numerous other aspects of the host response that one can 
delve deeply into. The scope of this dissertation pertained to developing characteristics related to 
the macrophage response and related extracellular events. However, it is certainly possible to go 
further into assessing other factors of the immune response, such as specific changes in other 
growth factors and protein molecules. Further information about the downstream effects by 
considering fibroblast behavior and environmental indicators of tissue degradation.  
It is also important to note that the use of New Zealand white rabbit provided advantages, 
also has its disadvantages in the translational hierarchy. While it served as a moderately-sized 
animal for mesh implantation via lumbar colpopexy, there remains the future steps that need to be 
taken in primate implants and human trials before translating the concepts to the clinic.  
An important limitation was the lack of comparison to native vaginal tissue in the ball-
burst mechanical testing outcomes. While it most certainly serves as an appropriate control, due 
to the lack of resources in obtaining native rabbit vagina, the data presented earlier utilizes the 
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different groups of mesh. Future development would most definitely include native vaginal tissue 
as well to better understand the structural properties.  
This study focused on an overall histological characterization utilizing multiple staining 
methodologies to evaluate mesh host response. Another limitation is that it is possible to expand 
the analyses with even more metrics of immunolabeling with other characteristic markers of the 
dynamic immune response, such as fibroblasts and T cells along with markers of apoptosis and 
cellular proliferation to better understand the stages of tissue remodeling and the wound healing 
process. In the case of elastin metabolism, it would greatly add to the study if further analyses on 
markers of elastin metabolism, such as lysyl oxidase like-1, fibulin-5, and matrix-
metalloproteinases were included. Overall, another distinction in this study was to assess the 
response to mesh, without inducing prolapse in the animal model itself, nor utilizing a specific 
knockout model that may represent prolapse conditions. This study is just the beginning of 
developing an overarching system of analysis for mesh host response at different time points. 






Appendix A Coating Stability information 
Table 8: Coating Stability Requirements 
Type Storage/Stability 
Pristine Mesh Room Temperature (Desiccator) (indefinitely)  
Plasma Irradiated Mesh Room Temperature (Desiccator) (use within 1 -
2 weeks)  
Core Coating Mesh (no cytokines) 4°C, Fridge (1 month)  
Cytokine + coating Mesh -20°C, Freezer (1 month)  
Polymer 0.2 um Filtering everything  
Chitosan (RT, chemical cabinet) 2 mg/mL in 0.5% Acetic Acid with UltraPure 
Water 
Dermatan Sulfate (4°C box)  10 mg/mL stock in UltraPure Water, then 




Appendix B Immunohistochemistry M1/M2 Macrophage Surface Markers 
Table 9: Immunohistochemistry M1/M2 Marker Validation 
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